<!DOCTYPE html>
<!--[if lt IE 7]> <html class="ie6 no-js light_layout" lang="en"> <![endif]-->
<!--[if IE 7]>    <html class="ie7 no-js light_layout" lang="en"> <![endif]-->
<!--[if IE 8]>    <html class="ie8 no-js light_layout" lang="en"> <![endif]-->
<!--[if gt IE 8]><!-->
<html class='no-js light_layout' lang='en'>
<!--<![endif]-->
<head>
<title>Ebola Drug ZMapp's Development Delayed by Pentagon Agency - Businessweek</title>
<meta content='BW' name='source'>
<meta content='article' name='content_type'>
<meta content="One promising treatment might have averted an epidemic. Why wasn't it ready in time?" name='description'>
<meta content='Brendan Greeley, Caroline Chen' name='author'>
<meta content='politics_and_policy' name='channel'>
<meta content='White House, Africa, Health Care, Science &amp; Research, Policy' name='department'>
<meta content='2014-09-24T06:05:58-04:00' name='pub_date'>

<meta content="Biomedical Advanced Research and Development Agency,Centers for Disease Control and Prevention,Defense Threat Reduction Agency,Ebola,Ebola Outbreak,Ken Brantly,Mapp Biopharmaceutical,Nancy Writebol,National Institute for Allergy and Infectious Diseases,zmapp" name="keywords" />
<meta content="Biomedical Advanced Research and Development Agency,Centers for Disease Control and Prevention,Defense Threat Reduction Agency,Ebola,Ebola Outbreak,Ken Brantly,Mapp Biopharmaceutical,Nancy Writebol,National Institute for Allergy and Infectious Diseases,zmapp" name="news_keywords" />
<meta content="http://www.businessweek.com/articles/2014-09-24/ebola-drug-zmapps-development-delayed-by-pentagon-agency" name="standout" />

<meta content="L7zxW9ChzqzPwbLIMzRbGzhn-Mly9AIDiF64J6DgQl0" name="google-site-verification" />
<meta content="dEHOKZR1s6GmOfGrPHHJFrXJwDoZXW6BjpnhmxPzRCE" name="google-site-verification" />
<meta content="nm_Na3kYYwG-eQKKUQs9A07nqn-GlhmC2qMzvutTDRA" name="google-site-verification" />

<meta charset='utf-8'>
<meta content='IE=edge,chrome=1' http-equiv='X-UA-Compatible'>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"bam.nr-data.net","licenseKey":"b220098848","applicationID":"138689","transactionName":"c1hbFURcXFsGRRYDRkReVg1TQB9EC1hO","queueTime":2,"applicationTime":425,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-515.min.js"}</script>
<script type="text/javascript">(window.NREUM||(NREUM={})).loader_config={xpid:"VgMEUVJACQAIUllb"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o?o:e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({QJf3ax:[function(t,e){function n(t){function e(e,n,a){t&&t(e,n,a),a||(a={});for(var c=s(e),f=c.length,u=i(a,o,r),d=0;f>d;d++)c[d].apply(u,n);return u}function a(t,e){f[t]=s(t).concat(e)}function s(t){return f[t]||[]}function c(){return n(e)}var f={};return{on:a,emit:e,create:c,listeners:s,_events:f}}function r(){return{}}var o="nr@context",i=t("gos");e.exports=n()},{gos:"7eSDFh"}],ee:[function(t,e){e.exports=t("QJf3ax")},{}],3:[function(t){function e(t,e,n,i,s){try{c?c-=1:r("err",[s||new UncaughtException(t,e,n)])}catch(f){try{r("ierr",[f,(new Date).getTime(),!0])}catch(u){}}return"function"==typeof a?a.apply(this,o(arguments)):!1}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function n(t){r("err",[t,(new Date).getTime()])}var r=t("handle"),o=t(5),i=t("ee"),a=window.onerror,s=!1,c=0;t("loader").features.err=!0,window.onerror=e,NREUM.noticeError=n;try{throw new Error}catch(f){"stack"in f&&(t(1),t(4),"addEventListener"in window&&t(2),window.XMLHttpRequest&&XMLHttpRequest.prototype&&XMLHttpRequest.prototype.addEventListener&&t(3),s=!0)}i.on("fn-start",function(){s&&(c+=1)}),i.on("fn-err",function(t,e,r){s&&(this.thrown=!0,n(r))}),i.on("fn-end",function(){s&&!this.thrown&&c>0&&(c-=1)}),i.on("internal-error",function(t){r("ierr",[t,(new Date).getTime(),!0])})},{1:8,2:5,3:9,4:7,5:21,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],4:[function(t){function e(){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var n=t("ee"),r=t("handle"),o=t(2);t("loader").features.stn=!0,t(1),n.on("fn-start",function(t){var e=t[0];e instanceof Event&&(this.bstStart=Date.now())}),n.on("fn-end",function(t,e){var n=t[0];n instanceof Event&&r("bst",[n,e,this.bstStart,Date.now()])}),o.on("fn-start",function(t,e,n){this.bstStart=Date.now(),this.bstType=n}),o.on("fn-end",function(t,e){r("bstTimer",[e,this.bstStart,Date.now(),this.bstType])}),n.on("pushState-start",function(){this.time=Date.now(),this.startPath=location.pathname+location.hash}),n.on("pushState-end",function(){r("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),"addEventListener"in window.performance&&(window.performance.addEventListener("webkitresourcetimingbufferfull",function(){r("bstResource",[window.performance.getEntriesByType("resource")]),window.performance.webkitClearResourceTimings()},!1),window.performance.addEventListener("resourcetimingbufferfull",function(){r("bstResource",[window.performance.getEntriesByType("resource")]),window.performance.clearResourceTimings()},!1)),document.addEventListener("scroll",e,!1),document.addEventListener("keypress",e,!1),document.addEventListener("click",e,!1)}},{1:6,2:8,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],5:[function(t,e){function n(t){i.inPlace(t,["addEventListener","removeEventListener"],"-",r)}function r(t){return t[1]}var o=(t(1),t("ee").create()),i=t(2)(o),a=t("gos");if(e.exports=o,n(window),"getPrototypeOf"in Object){for(var s=document;s&&!s.hasOwnProperty("addEventListener");)s=Object.getPrototypeOf(s);s&&n(s);for(var c=XMLHttpRequest.prototype;c&&!c.hasOwnProperty("addEventListener");)c=Object.getPrototypeOf(c);c&&n(c)}else XMLHttpRequest.prototype.hasOwnProperty("addEventListener")&&n(XMLHttpRequest.prototype);o.on("addEventListener-start",function(t){if(t[1]){var e=t[1];"function"==typeof e?this.wrapped=t[1]=a(e,"nr@wrapped",function(){return i(e,"fn-",null,e.name||"anonymous")}):"function"==typeof e.handleEvent&&i.inPlace(e,["handleEvent"],"fn-")}}),o.on("removeEventListener-start",function(t){var e=this.wrapped;e&&(t[1]=e)})},{1:21,2:22,ee:"QJf3ax",gos:"7eSDFh"}],6:[function(t,e){var n=(t(2),t("ee").create()),r=t(1)(n);e.exports=n,r.inPlace(window.history,["pushState"],"-")},{1:22,2:21,ee:"QJf3ax"}],7:[function(t,e){var n=(t(2),t("ee").create()),r=t(1)(n);e.exports=n,r.inPlace(window,["requestAnimationFrame","mozRequestAnimationFrame","webkitRequestAnimationFrame","msRequestAnimationFrame"],"raf-"),n.on("raf-start",function(t){t[0]=r(t[0],"fn-")})},{1:22,2:21,ee:"QJf3ax"}],8:[function(t,e){function n(t,e,n){var r=t[0];"string"==typeof r&&(r=new Function(r)),t[0]=o(r,"fn-",null,n)}var r=(t(2),t("ee").create()),o=t(1)(r);e.exports=r,o.inPlace(window,["setTimeout","setInterval","setImmediate"],"setTimer-"),r.on("setTimer-start",n)},{1:22,2:21,ee:"QJf3ax"}],9:[function(t,e){function n(){c.inPlace(this,d,"fn-")}function r(t,e){c.inPlace(e,["onreadystatechange"],"fn-")}function o(t,e){return e}var i=t("ee").create(),a=t(1),s=t(2),c=s(i),f=s(a),u=window.XMLHttpRequest,d=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"];e.exports=i,window.XMLHttpRequest=function(t){var e=new u(t);try{i.emit("new-xhr",[],e),f.inPlace(e,["addEventListener","removeEventListener"],"-",function(t,e){return e}),e.addEventListener("readystatechange",n,!1)}catch(r){try{i.emit("internal-error",[r])}catch(o){}}return e},window.XMLHttpRequest.prototype=u.prototype,c.inPlace(XMLHttpRequest.prototype,["open","send"],"-xhr-",o),i.on("send-xhr-start",r),i.on("open-xhr-start",r)},{1:5,2:22,ee:"QJf3ax"}],10:[function(t){function e(t){if("string"==typeof t&&t.length)return t.length;if("object"!=typeof t)return void 0;if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if("undefined"!=typeof FormData&&t instanceof FormData)return void 0;try{return JSON.stringify(t).length}catch(e){return void 0}}function n(t){var n=this.params,r=this.metrics;if(!this.ended){this.ended=!0;for(var i=0;c>i;i++)t.removeEventListener(s[i],this.listener,!1);if(!n.aborted){if(r.duration=(new Date).getTime()-this.startTime,4===t.readyState){n.status=t.status;var a=t.responseType,f="arraybuffer"===a||"blob"===a||"json"===a?t.response:t.responseText,u=e(f);if(u&&(r.rxSize=u),this.sameOrigin){var d=t.getResponseHeader("X-NewRelic-App-Data");d&&(n.cat=d.split(", ").pop())}}else n.status=0;r.cbTime=this.cbTime,o("xhr",[n,r,this.startTime])}}}function r(t,e){var n=i(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.sameOrigin=n.sameOrigin}if(window.XMLHttpRequest&&XMLHttpRequest.prototype&&XMLHttpRequest.prototype.addEventListener&&!/CriOS/.test(navigator.userAgent)){t("loader").features.xhr=!0;var o=t("handle"),i=t(2),a=t("ee"),s=["load","error","abort","timeout"],c=s.length,f=t(1);t(4),t(3),a.on("new-xhr",function(){this.totalCbs=0,this.called=0,this.cbTime=0,this.end=n,this.ended=!1,this.xhrGuids={}}),a.on("open-xhr-start",function(t){this.params={method:t[0]},r(this,t[1]),this.metrics={}}),a.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid)}),a.on("send-xhr-start",function(t,n){var r=this.metrics,o=t[0],i=this;if(r&&o){var f=e(o);f&&(r.txSize=f)}this.startTime=(new Date).getTime(),this.listener=function(t){try{"abort"===t.type&&(i.params.aborted=!0),("load"!==t.type||i.called===i.totalCbs&&(i.onloadCalled||"function"!=typeof n.onload))&&i.end(n)}catch(e){try{a.emit("internal-error",[e])}catch(r){}}};for(var u=0;c>u;u++)n.addEventListener(s[u],this.listener,!1)}),a.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),a.on("xhr-load-added",function(t,e){var n=""+f(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),a.on("xhr-load-removed",function(t,e){var n=""+f(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),a.on("addEventListener-end",function(t,e){e instanceof XMLHttpRequest&&"load"===t[0]&&a.emit("xhr-load-added",[t[1],t[2]],e)}),a.on("removeEventListener-end",function(t,e){e instanceof XMLHttpRequest&&"load"===t[0]&&a.emit("xhr-load-removed",[t[1],t[2]],e)}),a.on("fn-start",function(t,e,n){e instanceof XMLHttpRequest&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=(new Date).getTime()))}),a.on("fn-end",function(t,e){this.xhrCbStart&&a.emit("xhr-cb-time",[(new Date).getTime()-this.xhrCbStart,this.onload,e],e)})}},{1:"XL7HBI",2:11,3:9,4:5,ee:"QJf3ax",handle:"D5DuLP",loader:"G9z0Bl"}],11:[function(t,e){e.exports=function(t){var e=document.createElement("a"),n=window.location,r={};e.href=t,r.port=e.port;var o=e.href.split("://");return!r.port&&o[1]&&(r.port=o[1].split("/")[0].split("@").pop().split(":")[1]),r.port&&"0"!==r.port||(r.port="https"===o[0]?"443":"80"),r.hostname=e.hostname||n.hostname,r.pathname=e.pathname,r.protocol=o[0],"/"!==r.pathname.charAt(0)&&(r.pathname="/"+r.pathname),r.sameOrigin=!e.hostname||e.hostname===document.domain&&e.port===n.port&&e.protocol===n.protocol,r}},{}],gos:[function(t,e){e.exports=t("7eSDFh")},{}],"7eSDFh":[function(t,e){function n(t,e,n){if(r.call(t,e))return t[e];var o=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:o,writable:!0,enumerable:!1}),o}catch(i){}return t[e]=o,o}var r=Object.prototype.hasOwnProperty;e.exports=n},{}],D5DuLP:[function(t,e){function n(t,e,n){return r.listeners(t).length?r.emit(t,e,n):(o[t]||(o[t]=[]),void o[t].push(e))}var r=t("ee").create(),o={};e.exports=n,n.ee=r,r.q=o},{ee:"QJf3ax"}],handle:[function(t,e){e.exports=t("D5DuLP")},{}],XL7HBI:[function(t,e){function n(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:i(t,o,function(){return r++})}var r=1,o="nr@id",i=t("gos");e.exports=n},{gos:"7eSDFh"}],id:[function(t,e){e.exports=t("XL7HBI")},{}],loader:[function(t,e){e.exports=t("G9z0Bl")},{}],G9z0Bl:[function(t,e){function n(){var t=l.info=NREUM.info;if(t&&t.licenseKey&&t.applicationID&&f&&f.body){s(h,function(e,n){e in t||(t[e]=n)}),l.proto="https"===p.split(":")[0]||t.sslForHttp?"https://":"http://",a("mark",["onload",i()]);var e=f.createElement("script");e.src=l.proto+t.agent,f.body.appendChild(e)}}function r(){"complete"===f.readyState&&o()}function o(){a("mark",["domContent",i()])}function i(){return(new Date).getTime()}var a=t("handle"),s=t(1),c=window,f=c.document,u="addEventListener",d="attachEvent",p=(""+location).split("?")[0],h={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-515.min.js"},l=e.exports={offset:i(),origin:p,features:{}};f[u]?(f[u]("DOMContentLoaded",o,!1),c[u]("load",n,!1)):(f[d]("onreadystatechange",r),c[d]("onload",n)),a("mark",["firstbyte",i()])},{1:20,handle:"D5DuLP"}],20:[function(t,e){function n(t,e){var n=[],o="",i=0;for(o in t)r.call(t,o)&&(n[i]=e(o,t[o]),i+=1);return n}var r=Object.prototype.hasOwnProperty;e.exports=n},{}],21:[function(t,e){function n(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(0>o?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=n},{}],22:[function(t,e){function n(t){return!(t&&"function"==typeof t&&t.apply&&!t[i])}var r=t("ee"),o=t(1),i="nr@wrapper",a=Object.prototype.hasOwnProperty;e.exports=function(t){function e(t,e,r,a){function nrWrapper(){var n,i,s,f;try{i=this,n=o(arguments),s=r&&r(n,i)||{}}catch(d){u([d,"",[n,i,a],s])}c(e+"start",[n,i,a],s);try{return f=t.apply(i,n)}catch(p){throw c(e+"err",[n,i,p],s),p}finally{c(e+"end",[n,i,f],s)}}return n(t)?t:(e||(e=""),nrWrapper[i]=!0,f(t,nrWrapper),nrWrapper)}function s(t,r,o,i){o||(o="");var a,s,c,f="-"===o.charAt(0);for(c=0;c<r.length;c++)s=r[c],a=t[s],n(a)||(t[s]=e(a,f?s+o:o,i,s,t))}function c(e,n,r){try{t.emit(e,n,r)}catch(o){u([o,e,n,r])}}function f(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){u([r])}for(var o in t)a.call(t,o)&&(e[o]=t[o]);return e}function u(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=r),e.inPlace=s,e.flag=i,e}},{1:21,ee:"QJf3ax"}]},{},["G9z0Bl",3,10,4]);</script>
<!-- * font definitions */ -->
<style>
  @font-face {
    font-family: 'BloombergLBold';
      src: url("http://static.btrd.net/assets/type/bloombergl_heavy.eot?#iefix") format('embedded-opentype'),
           url('http://static.btrd.net/assets/type/bloombergl_heavy.ttf') format('truetype');
      font-weight: bold;
      font-style: normal;
  }
  @font-face {
    font-family:'BWHaasHead';
    src: url('http://static.btrd.net/assets/type/hinted/haas/bwhaasgroteskhead-95black.eot?#iefix') format('eot'),
         url('http://static.btrd.net/assets/type/hinted/haas/bwhaasgroteskhead-95black.woff') format('woff'),
         url('http://static.btrd.net/assets/type/haas/bwhaasgroteskhead-95black.ttf') format('truetype');
  
    font-style: normal;
    font-weight: 700;
    font-stretch: normal;
  }
  @font-face {
    font-family:'BWHaasHead75Bold';
    src: url('http://static.btrd.net/assets/type/hinted/haas75/bwhaasgroteskhead-75bold.eot?#iefix') format('eot'),
         url('http://static.btrd.net/assets/type/hinted/haas75/bwhaasgroteskhead-75bold.woff') format('woff'),
         url('http://static.btrd.net/assets/type/haas75/bwhaasgrotesktext-75bold.ttf') format('truetype');
    font-style: normal;
    font-weight: 700;
    font-stretch: normal;
  }
  @font-face {
    font-family:'BWHaasRegular';
    src: url('http://static.btrd.net/assets/web_fonts/bwhaasgroteskhead-65medium.eot?#iefix') format('eot'),
         url('http://static.btrd.net/assets/web_fonts/bwhaasgroteskhead-65medium.woff') format('woff'),
         url('http://static.btrd.net/assets/web_fonts/bwhaasgrotesktext-65medium.ttf') format('truetype');
    font-style: normal;
    font-weight: 700;
    font-stretch: normal;
  }
</style>
<link href="http://static.btrd.net/assets/application-2965f151504559907746027d58a3b7ae.css" media="screen" rel="stylesheet" type="text/css" />

<link href="http://static.btrd.net/assets/content-b0162cf4173963330e4669cb4bad8a69.css" media="screen" rel="stylesheet" type="text/css" />


<meta content="Businessweek.com" property="og:site_name" />
<meta content="article" property="og:type" />
<meta content="How the U.S. Screwed Up in the Fight Against Ebola" property="og:title" />
<meta content="One promising treatment might have averted an epidemic. Why wasn&#x27;t it ready in time?" property="og:description" />
<meta content="http://images.bwbx.io/cms/2014-09-23/0923_ebola_whitehouse_970.jpg" property="og:image" />
<meta content="summary" name="twitter:card" />
<meta content="@BW" name="twitter:site" />


<!-- BEGIN Krux Control Tag -->
<script src="http://static.btrd.net/assets/krux-2219e2e7b21a9027972af37eaeb5ee88.js" type="text/javascript"></script>

<script type='application/ld+json'>
{
"@context": "http://schema.org",
"@type": "NewsArticle",
"headline": "How the U.S. Screwed Up in the Fight Against Ebola",
"url": "http://www.businessweek.com/articles/2014-09-24/ebola-drug-zmapps-development-delayed-by-pentagon-agency",
"thumbnailUrl": "http://images.bwbx.io/cms/2014-09-23/0923_ebola_whitehouse_970-630x420.jpg",
"dateCreated": "2014-09-24T10:05:58Z",
"articleSection": "Politics &amp; Policy",
"creator": "Brendan Greeley, Caroline Chen",
"keywords": "Africa, Biotechnology, Economy &amp;amp; Policy, Emerging Markets, Global Finance &amp;amp; Markets, International, Pharmaceutical Industry, Regulation, Research, Research &amp;amp; Development, Science, Social Issues, story"
}
</script>




<script>
  var AVAILABLE_BUCKETS = []
</script>
<script src="http://static.btrd.net/assets/buckets-d84e1f4dcb5b5442542ec0a4b3fb1865.js" type="text/javascript"></script>
<meta content='width=1000px' name='viewport'>
<script>
  var googletag = googletag || {};
  googletag.cmd = googletag.cmd || [];
  (function() {
    var gads = document.createElement("script");
    gads.async = true;
    gads.type = "text/javascript";
    var useSSL = "https:" == document.location.protocol;
    gads.src = (useSSL ? "https:" : "http:") + "//www.googletagservices.com/tag/js/gpt.js";
    var node =document.getElementsByTagName("script")[0];
    node.parentNode.insertBefore(gads, node);
   })();
</script>

<script src="http://static.btrd.net/assets/jquery.dfp.gpt.logger.override-33aaf061a2d76891ddeea42a7aa62b43.js" type="text/javascript"></script>
<script>
  var ROOT_URL          = "http://www.bloomberg.com/";
  var FACEBOOK_APP_KEY  = "381515401910729";
  var FACEBOOK_APP_NS   = "bw_prod";
  var COOKIE_DOMAIN     = "businessweek.com";
  var SECURE_DOMAIN_URL = "https://secure.businessweek.com";
  var STICKY_NEWS_ENGINE= "none";
  var VIDEO_AD_PREFIX   = "http://ad.doubleclick.net/N5262/pfadx/";
  var VIDEO_SITE        = "mgh.bw.video";
  var VIDEO_SUB_SITE    = "/general";
  var DOUBLECLICK_URL_PREFIX = "http://ad.doubleclick.net/N5262";
  var AD_SITE           = "bw";
  var AD_LAYOUT_DESC    = "article no_pagination  channel politics_and_policy";
  var AD_SUB_SITE       = ".politicspolicy/white_house";
  if (AD_LAYOUT_DESC.indexOf("video") >= 0){
      AD_SITE           = VIDEO_SITE;
      AD_SUB_SITE       = VIDEO_SUB_SITE;
  }
  var AD_ZONE           = ""; // TODO: this is used to tag "department" pages
  var AD_KEYWORD        = "issue14_40"; //TODO: This is used on article and department index pages
  var AD_URL            = (window.location.pathname == undefined) ? "/" : window.location.pathname.replace(/\/?$/, '/');
  var YIELDEX           = true;
  var AD_INTERVAL_TO    = 450;
  var AD_DEPT_TRACKING  = false; //Temporary flag to be removed when the time is right
  
  var VIDEO_AD_SIZE     = "1x1";
  var VIDEO_AD_YIELD_EX = (YIELDEX) ? '"u=sz='+VIDEO_AD_SIZE+'|' + ';' : '';
  var RANDOM_NUMBER     = ("1"+(""+Math.random()).substring(2,11));
  var VIDEO_AD_SUFFIX   = ";sz="+VIDEO_AD_SIZE+";tile=15;tp_video=null;dcmt=text/html;"+encodeURIComponent(VIDEO_AD_YIELD_EX)+"ord="+RANDOM_NUMBER+";";
  var TILE_NUMBER       = 1;
  var URL_HASH          = window.location.hash.replace(/#video=/, '');
  var google_ad_channel = "6537084077 3231123392";
  var discus_car, lead_module_interval;
  var NEGATIVE_AD_CATEGORIES = "bw_bpkeywords,bw_current_events,bw_delta,bw_synchrony,bw_sydney_crisis";
  var AD_SLOTS = {};
  var GPT_ADS_ENABLED = true;
  var GPT_NETWORK_ID = 5262;
  var SHOW_NATIVE = "true";
  var NATIVE_PROPERTY_ID = "NA-BUSIWEEKCOM-11236051";
</script>
<script>
  if (!GPT_ADS_ENABLED) {
    var COMPANION_AD_SITE = AD_SITE + AD_SUB_SITE; //these create the video companion ads
    googletag.cmd.push(function() {
      googletag.defineSlot(COMPANION_AD_SITE, [728,  90], 'header-companion-ad').addService(googletag.companionAds()).addService(googletag.pubads());
      googletag.defineSlot(COMPANION_AD_SITE, [300, 250], 'right-companion-ad').addService(googletag.companionAds()).addService(googletag.pubads());
      googletag.defineSlot(COMPANION_AD_SITE, [728,  90], 'bottom-companion-ad').addService(googletag.companionAds()).addService(googletag.pubads());
      googletag.companionAds().setRefreshUnfilledSlots(true);
      //googletag.pubads().disableInitialLoad();
      googletag.enableServices();
    });
  }
</script>

</head>
<body class='article no_pagination  channel politics_and_policy' data-action='show' data-controller='articles' itemscope itemtype='http://schema.org/WebPage'>
<div id='fb-root'></div>

<link href="//cdn.gotraffic.net/business/public/stylesheets/snippet_application.a45a8dde.css" rel='stylesheet' type='text/css'>
<script data-exclude='true' src='//cdn.gotraffic.net/business/public/javascripts/application.24c97a10.js' type='text/javascript'></script>
<script data-exclude='true' src='//cdn.gotraffic.net/projector/latest/bplayer.js' type='text/javascript'></script>
<div class='business-snippet' id='snipper_header'>
<div class="snippet-view business-snippet default-layout section-front" data-view-uid="snippetHeaderViews"><div data-view-uid="snippetHeaderViews_1"><div class="tophat">
    <section class="tophat-menu">
        <h1 class="tophat-menu__link-toggle">Bloomberg the Company</h1>
        <a href="https://bba.bloomberg.net/?utm_source=bloomberg-menu" class="tophat-menu__link-bba">Bloomberg Anywhere Login</a>
    </section>

    <div class="tophat__sitemap">

        <div class="tophat__categories">

            <div class="tophat__close-sitemap-button"></div>

            <section class="tophat-category">
                <h1 class="tophat-category__title">Bloomberg</h1>
                <div class="tophat-category__content">
                    <p class="tophat-category__text">
                        Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
                    </p>
                </div>
            </section>

            <section class="tophat-category">
                <h1 class="tophat-category__title">Company</h1>
                <ul class="tophat-category__content">
                    <li><a href="http://www.bloomberg.com/company/?utm_source=bloomberg-menu" class="tophat-category__link">About</a></li>
                    <li><a href="http://www.bloomberg.com/company/careers/?utm_source=bloomberg-menu" class="tophat-category__link">Careers</a></li>
                    <li><a href="http://www.bloomberg.com/company/contacts/?utm_source=bloomberg-menu" class="tophat-category__link">Contacts</a></li>
                    <li><a href="http://www.bloomberg.com/diversity-inclusion/?utm_source=bloomberg-menu" class="tophat-category__link">Diversity &amp; Inclusion</a></li>
                    <li><a href="http://www.bloomberg.com/philanthropy/?utm_source=bloomberg-menu" class="tophat-category__link">Philanthropy &amp; Engagement</a></li>
                    <li><a href="http://www.bloomberg.com/company/regional-sites/?utm_source=bloomberg-menu" class="tophat-category__link">Regional Sites</a></li>
                    <li><a href="http://www.bloomberg.com/bcause/?utm_source=bloomberg-menu" class="tophat-category__link">Sustainability</a></li>
                </ul>
            </section>

            <section class="tophat-category">
                <h1 class="tophat-category__title">Financial Products</h1>
                <ul class="tophat-category__content">
                    <li><a href="http://www.bloomberg.com/professional/?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Professional</a></li>
                    <li><a href="http://www.bloombergtradebook.com?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Tradebook</a></li>
                    <li><a href="http://www.bloombergbriefs.com?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Briefs</a></li>
                    <li><a href="http://www.bloombergindexes.com?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Indexes</a></li>
                    <li><a href="http://www.bloombergsef.com?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg SEF</a></li>
                    <li><a href="http://about.bloomberginstitute.com?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Institute</a></li>
                    <li><a href="http://www.bloomberglabs.com?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Labs</a></li>
                    <li><a href="http://www.bloomberg.com/professional/systems-support/service-center/?utm_source=bloomberg-menu" class="tophat-category__link">Service Center</a></li>
                </ul>
            </section>

            <section class="tophat-category">
                <h1 class="tophat-category__title">Enterprise Products</h1>
                <ul class="tophat-category__content">
                    <li><a href="http://www.bloomberg.com/enterprise/?utm_source=bloomberg-menu" class="tophat-category__link">Enterprise Solutions</a></li>
                    <li><a href="http://www.bloomberg.com/trading-solutions/?utm_source=bloomberg-menu" class="tophat-category__link">Trading Solutions</a></li>
                    <li><a href="http://www.bloomberg.com/vault/?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Vault</a></li>
                </ul>
            </section>

            <section class="tophat-category">
                <h1 class="tophat-category__title">Media</h1>
                <ul class="tophat-category__content">
                    <li><a href="http://www.bloomberg.com/?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Business</a></li>
                    <li><a href="http://www.bloomberg.com/politics/?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Politics</a></li>
                    <li><a href="http://www.bloombergview.com/?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg View</a></li>
                    <li><a href="http://www.bloomberg.com/businessweek/?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Businessweek</a></li>
                    <li><a href="http://www.bloomberg.com/markets/markets-magazine/?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Markets</a></li>
                    <li><a href="http://www.bloomberg.com/content-service/?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Content Service</a></li>
                    <li><a href="http://www.bloomberglive.com/?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Live</a></li>
                    <li><a href="http://www.bloombergmedia.com/?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Media</a></li>
                    <li><a href="http://www.bloomberg.com/mobile/?utm_source=bloomberg-menu" class="tophat-category__link">Mobile Apps</a></li>
                </ul>
            </section>

            <section class="tophat-category">
                <h1 class="tophat-category__title">Customer Support</h1>
                <ul class="tophat-category__content">
                    <li class="tophat-category__item">
                        <p class="tophat-category__text">Americas</p>
                        <p class="tophat-category__text">+1 212 318 2000</p>
                    </li>
                    <li class="tophat-category__item">
                        <p class="tophat-category__text">Europe, Middle East, &amp; Africa</p>
                        <p class="tophat-category__text">+44 20 7330 7500</p>
                    </li>
                    <li class="tophat-category__item">
                        <p class="tophat-category__text">Asia Pacific</p>
                        <p class="tophat-category__text">+65 6212 1000</p>
                    </li>
                </ul>
            </section>                

            <section class="tophat-category">
                <h1 class="tophat-category__title">Follow Us</h1>
                <ul class="tophat-category__content">
                    <li><a href="http://www.facebook.com/Bloomberglp" class="tophat-category__social-link facebook" data-network="facebook" target="_blank">
                        Facebook
                    </a></li>

                    <li><a href="https://twitter.com/bloomberg" class="tophat-category__social-link twitter" data-network="twitter" target="_blank">
                        Twitter
                    </a></li>

                    <li><a href="https://www.linkedin.com/company/2494" class="tophat-category__social-link linkedin" data-network="linkedin" target="_blank">
                        LinkedIn
                    </a></li>
                </ul>
            </section>                                

            <section class="tophat-category">
                <h1 class="tophat-category__title">Industry Products</h1>
                <ul class="tophat-category__content">
                    <li><a href="http://about.bgov.com/?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Government</a></li>
                    <li><a href="http://www.bna.com/?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg Law/BNA</a></li>
                    <li><a href="http://about.bnef.com/?utm_source=bloomberg-menu" class="tophat-category__link">Bloomberg New Energy Finance</a></li>
                </ul>
            </section>                

        </div>

    </div>



</div>
</div><div class="persistent-header-placeholder" data-view-uid="snippetHeaderViews_2"><div class="persistent-header">
    <div class="persistent-header__bounding-width">
        <div class="persistent-header__container">

            <div class="persistent-header__just-so-logo-link-isnt-full-width">
                <a href="http://www.bloomberg.com/" class="persistent-header__logo-link make-svg-clickable" title="Bloomberg Business">
                    <object class="persistent-header__logo-image normal" type="image/svg+xml" data="//cdn.gotraffic.net/business/public/images/logos/BB-Logo-H1.c318357b.svg" title="Bloomberg Business Logo">
                    </object>

                    <object class="persistent-header__logo-image vertical" type="image/svg+xml" data="//cdn.gotraffic.net/business/public/images/logos/BB-Logo-V.313783e5.svg" title="Bloomberg Business Logo">
                    </object>

                    <object class="persistent-header__logo-image horizontal" type="image/svg+xml" data="//cdn.gotraffic.net/business/public/images/logos/BB-Logo-H.37109099.svg" title="Bloomberg Business Logo">
                    </object>

                    <object class="persistent-header__logo-image special-section-front-vertical-logo" type="image/svg+xml" data="//cdn.gotraffic.net/business/public/images/logos/BB-Logo-V-SFF.84957dfc.svg" title="Bloomberg Business Logo">
                    </object>

                    <object class="persistent-header__logo-image special-section-front-horizontal-logo" type="image/svg+xml" data="//cdn.gotraffic.net/business/public/images/logos/BB-Logo-H-SFF.cfc95f5f.svg" title="Bloomberg Business Logo">
                    </object>

                </a>
                <span class="persistent-header__menu">
                    Menu
                </span>
            </div>

            <div class="persistent-header__content">
                <div class="persistent-header__content-container">
                    <div class="persistent-header__nav">
                            <div class="persistent-header__nav-item news" data-key="news">
                                <a href="http://www.bloomberg.com/" class="persistent-header__link">
                                    News
                                </a>
                            </div>
                            <div class="persistent-header__nav-item markets" data-key="markets">
                                <a href="http://www.bloomberg.com/markets" class="persistent-header__link">
                                    Markets
                                </a>
                            </div>
                            <div class="persistent-header__nav-item insights" data-key="insights">
                                <a href="http://www.bloomberg.com/insights" class="persistent-header__link">
                                    Insights
                                </a>
                            </div>
                            <div class="persistent-header__nav-item live_tv" data-key="live_tv">
                                <a href="http://www.bloomberg.com/live" class="persistent-header__link">
                                    Live TV
                                </a>
                            </div>
                    </div>

                    <div class="persistent-header-reading-now">
                        <span class="persistent-header-reading-now__title">Now Reading:</span>
                        <span class="persistent-header-reading-now__headline"></span>
                    </div>

                    <div class="persistent-header__social showable">
                        <div class="social-share__container">
                            <div class="social-share">
                                <div class="social-share__visible"></div>
                                <div class="social-share__additional"></div>
                                <div class="social-share__more"></div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="persistent-header__search-box">
                    <div class="persistent-header__search-close"></div>
                    <label class="persistent-header__search-label">
                        <input type="search" class="persistent-header__search-input">
                    </label>
                </div>
            </div>

            <span class="persistent-header__search-button">
                <a href="http://www.bloomberg.com/search" class="persistent-header__link">
                    Search
                </a>
            </span>
        </div>

        <a class="mini-live-player" href="http://www.bloomberg.com/live">
        <div data-view-uid="snippetHeaderViews_2_3"><div class="video-player live-video-player">
    <div class="video-player__image">
    </div>
</div>
</div></a>
    </div>

    <div class="persistent-header__submenu-container"><div data-view-uid="snippetHeaderViews_2_1"><section class="navigation-submenu">

    <div class="navigation-submenu__container">

            <div id="news" class="navigation-submenu__vertical">

                <ul class="navigation-submenu__categories">
                        <li class="navigation-submenu__category-item" id="latest" data-key="latest">
                            <a href="http://www.bloomberg.com/" class="navigation-submenu__category-link">
                                Latest
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="world" data-key="world">
                            <a href="http://www.bloomberg.com/news/world" class="navigation-submenu__category-link">
                                World
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="industries" data-key="industries">
                            <a href="http://www.bloomberg.com/news/industries" class="navigation-submenu__category-link">
                                Industries
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="science_energy" data-key="science_energy">
                            <a href="http://www.bloomberg.com/news/science-energy" class="navigation-submenu__category-link">
                                Science+Energy
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="technology" data-key="technology">
                            <a href="http://www.bloomberg.com/technology" class="navigation-submenu__category-link">
                                Technology
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="design" data-key="design">
                            <a href="http://www.bloomberg.com/news/design" class="navigation-submenu__category-link">
                                Design
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="culture" data-key="culture">
                            <a href="http://www.bloomberg.com/news/culture" class="navigation-submenu__category-link">
                                Culture
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="graphics" data-key="graphics">
                            <a href="http://www.bloomberg.com/graphics" class="navigation-submenu__category-link">
                                Graphics
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="pursuits" data-key="pursuits">
                            <a href="http://www.bloomberg.com/pursuits" class="navigation-submenu__category-link">
                                Pursuits
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="view" data-key="view">
                            <a href="http://www.bloombergview.com" class="navigation-submenu__category-link">
                                View
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="politics" data-key="politics">
                            <a href="http://www.bloomberg.com/politics" class="navigation-submenu__category-link">
                                Politics
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="businessweek" data-key="businessweek">
                            <a href="http://www.bloomberg.com/businessweek" class="navigation-submenu__category-link">
                                Businessweek
                            </a>
                        </li>
                </ul>

            </div>
            <div id="markets" class="navigation-submenu__vertical">

                <ul class="navigation-submenu__categories">
                        <li class="navigation-submenu__category-item" id="stocks" data-key="stocks">
                            <a href="http://www.bloomberg.com/markets/stocks" class="navigation-submenu__category-link">
                                Stocks
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="currencies" data-key="currencies">
                            <a href="http://www.bloomberg.com/markets/currencies" class="navigation-submenu__category-link">
                                Currencies
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="commodities" data-key="commodities">
                            <a href="http://www.bloomberg.com/markets/commodities/futures" class="navigation-submenu__category-link">
                                Commodities
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="rates_bonds" data-key="rates_bonds">
                            <a href="http://www.bloomberg.com/markets/rates-bonds" class="navigation-submenu__category-link">
                                Rates+Bonds
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="magazine" data-key="magazine">
                            <a href="http://www.bloomberg.com/markets/markets-magazine" class="navigation-submenu__category-link">
                                Magazine
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="benchmark" data-key="benchmark">
                            <a href="http://www.bloomberg.com/markets/benchmark" class="navigation-submenu__category-link">
                                Benchmark
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="watchlist" data-key="watchlist">
                            <a href="http://www.bloomberg.com/markets/watchlist" class="navigation-submenu__category-link">
                                Watchlist
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="economic_calendar" data-key="economic_calendar">
                            <a href="http://www.bloomberg.com/markets/economic-calendar" class="navigation-submenu__category-link">
                                Economic Calendar
                            </a>
                        </li>
                </ul>

            </div>
            <div id="insights" class="navigation-submenu__vertical">

                <ul class="navigation-submenu__categories">
                        <li class="navigation-submenu__category-item" id="latest" data-key="latest">
                            <a href="http://www.bloomberg.com/insights" class="navigation-submenu__category-link">
                                Latest
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="game_plan" data-key="game_plan">
                            <a href="http://www.bloomberg.com/game-plan" class="navigation-submenu__category-link">
                                Game Plan
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="business_schools" data-key="business_schools">
                            <a href="http://www.bloomberg.com/business-schools" class="navigation-submenu__category-link">
                                Business Schools
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="small_business" data-key="small_business">
                            <a href="http://www.bloomberg.com/small-business" class="navigation-submenu__category-link">
                                Small Business
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="personal_finance" data-key="personal_finance">
                            <a href="http://www.bloomberg.com/personal-finance" class="navigation-submenu__category-link">
                                Personal Finance
                            </a>
                        </li>
                </ul>

            </div>
            <div id="live_tv" class="navigation-submenu__vertical">

                <ul class="navigation-submenu__categories">
                        <li class="navigation-submenu__category-item" id="watch_now" data-key="watch_now">
                            <a href="http://www.bloomberg.com/live" class="navigation-submenu__category-link">
                                Watch Now
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="video" data-key="video">
                            <a href="http://www.bloomberg.com/video" class="navigation-submenu__category-link">
                                Video
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="schedule_shows" data-key="schedule_shows">
                            <a href="http://www.bloomberg.com/live/schedule-shows" class="navigation-submenu__category-link">
                                Schedule + Shows
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="radio" data-key="radio">
                            <a href="http://www.bloomberg.com/radio" class="navigation-submenu__category-link">
                                Radio
                            </a>
                        </li>
                        <li class="navigation-submenu__category-item" id="events" data-key="events">
                            <a href="http://www.bloomberg.com/live/events" class="navigation-submenu__category-link">
                                Events
                            </a>
                        </li>
                </ul>

            </div>

        <div class="navigation-submenu__card-container">
        </div>

    </div>


</section>
</div></div>
<div data-view-uid="snippetHeaderViews_2_2"><div class="reading-progress">
    <div class="reading-progress__bar"></div>
</div>
</div></div>
</div></div>
</div>
<script type="text/javascript">
var SnippetApp = require('app/SnippetApp');
var snippetApp = new SnippetApp({"appRoot":"","assetManifest":{"public/images/500error.gif":"//cdn.gotraffic.net/business/public/images/500error.96cb50c5.gif","public/images/bbiz404.gif":"//cdn.gotraffic.net/business/public/images/bbiz404.3020e8d7.gif","public/images/fallback.jpg":"//cdn.gotraffic.net/business/public/images/fallback.269a48ad.jpg","public/images/favicons/apple-touch-icon-114x114.png":"//cdn.gotraffic.net/business/public/images/favicons/apple-touch-icon-114x114.4aeb3b13.png","public/images/favicons/apple-touch-icon-120x120.png":"//cdn.gotraffic.net/business/public/images/favicons/apple-touch-icon-120x120.616b256f.png","public/images/favicons/apple-touch-icon-144x144.png":"//cdn.gotraffic.net/business/public/images/favicons/apple-touch-icon-144x144.166dda65.png","public/images/favicons/apple-touch-icon-152x152.png":"//cdn.gotraffic.net/business/public/images/favicons/apple-touch-icon-152x152.c9951ac7.png","public/images/favicons/apple-touch-icon-180x180.png":"//cdn.gotraffic.net/business/public/images/favicons/apple-touch-icon-180x180.dc9ca3d6.png","public/images/favicons/apple-touch-icon-57x57.png":"//cdn.gotraffic.net/business/public/images/favicons/apple-touch-icon-57x57.bd486901.png","public/images/favicons/apple-touch-icon-60x60.png":"//cdn.gotraffic.net/business/public/images/favicons/apple-touch-icon-60x60.f457f1df.png","public/images/favicons/apple-touch-icon-72x72.png":"//cdn.gotraffic.net/business/public/images/favicons/apple-touch-icon-72x72.7d226513.png","public/images/favicons/apple-touch-icon-76x76.png":"//cdn.gotraffic.net/business/public/images/favicons/apple-touch-icon-76x76.4fb8818e.png","public/images/favicons/apple-touch-icon-precomposed.png":"//cdn.gotraffic.net/business/public/images/favicons/apple-touch-icon-precomposed.c3e3dfeb.png","public/images/favicons/apple-touch-icon.png":"//cdn.gotraffic.net/business/public/images/favicons/apple-touch-icon.dc9ca3d6.png","public/images/favicons/favicon-160x160.png":"//cdn.gotraffic.net/business/public/images/favicons/favicon-160x160.9b14619b.png","public/images/favicons/favicon-16x16.png":"//cdn.gotraffic.net/business/public/images/favicons/favicon-16x16.8cab4be4.png","public/images/favicons/favicon-192x192.png":"//cdn.gotraffic.net/business/public/images/favicons/favicon-192x192.03482356.png","public/images/favicons/favicon-32x32.png":"//cdn.gotraffic.net/business/public/images/favicons/favicon-32x32.fa02118e.png","public/images/favicons/favicon-96x96.png":"//cdn.gotraffic.net/business/public/images/favicons/favicon-96x96.6dbd1316.png","public/images/favicons/favicon.ico":"//cdn.gotraffic.net/business/public/images/favicons/favicon.9628b26e.ico","public/images/favicons/mstile-144x144.png":"//cdn.gotraffic.net/business/public/images/favicons/mstile-144x144.539def7a.png","public/images/favicons/mstile-150x150.png":"//cdn.gotraffic.net/business/public/images/favicons/mstile-150x150.05f21a40.png","public/images/favicons/mstile-310x150.png":"//cdn.gotraffic.net/business/public/images/favicons/mstile-310x150.07f7515d.png","public/images/favicons/mstile-310x310.png":"//cdn.gotraffic.net/business/public/images/favicons/mstile-310x310.b5b6727a.png","public/images/favicons/mstile-70x70.png":"//cdn.gotraffic.net/business/public/images/favicons/mstile-70x70.1b6952cd.png","public/images/feature_article/feature-arrow.svg":"//cdn.gotraffic.net/business/public/images/feature_article/feature-arrow.159d059a.svg","public/images/icons/ad_choices_icon.png":"//cdn.gotraffic.net/business/public/images/icons/ad_choices_icon.49173bcd.png","public/images/logos/BB-Logo-H-HP-TOP.svg":"//cdn.gotraffic.net/business/public/images/logos/BB-Logo-H-HP-TOP.3d81db4e.svg","public/images/logos/BB-Logo-H-SFF.svg":"//cdn.gotraffic.net/business/public/images/logos/BB-Logo-H-SFF.cfc95f5f.svg","public/images/logos/BB-Logo-H.svg":"//cdn.gotraffic.net/business/public/images/logos/BB-Logo-H.37109099.svg","public/images/logos/BB-Logo-H1.svg":"//cdn.gotraffic.net/business/public/images/logos/BB-Logo-H1.c318357b.svg","public/images/logos/BB-Logo-V-HP-TOP.svg":"//cdn.gotraffic.net/business/public/images/logos/BB-Logo-V-HP-TOP.a8517901.svg","public/images/logos/BB-Logo-V-SFF.svg":"//cdn.gotraffic.net/business/public/images/logos/BB-Logo-V-SFF.84957dfc.svg","public/images/logos/BB-Logo-V.svg":"//cdn.gotraffic.net/business/public/images/logos/BB-Logo-V.313783e5.svg","public/images/logos/BB-Politics.svg":"//cdn.gotraffic.net/business/public/images/logos/BB-Politics.8ba9ea31.svg","public/images/logos/BB-View.svg":"//cdn.gotraffic.net/business/public/images/logos/BB-View.465688fb.svg","public/images/logos/bloombergGraphics.svg":"//cdn.gotraffic.net/business/public/images/logos/bloombergGraphics.59cde388.svg","public/images/masks/0.svg":"//cdn.gotraffic.net/business/public/images/masks/0.6673ff57.svg","public/images/masks/1.svg":"//cdn.gotraffic.net/business/public/images/masks/1.878a21c9.svg","public/images/masks/2.svg":"//cdn.gotraffic.net/business/public/images/masks/2.f0f70f59.svg","public/images/masks/3.svg":"//cdn.gotraffic.net/business/public/images/masks/3.cd142ccc.svg","public/images/masks/4.svg":"//cdn.gotraffic.net/business/public/images/masks/4.fac7b759.svg","public/images/masks/5.svg":"//cdn.gotraffic.net/business/public/images/masks/5.487be3a1.svg","public/images/masks/6.svg":"//cdn.gotraffic.net/business/public/images/masks/6.831d863f.svg","public/images/masks/7.svg":"//cdn.gotraffic.net/business/public/images/masks/7.257607a5.svg","public/images/masks/8.svg":"//cdn.gotraffic.net/business/public/images/masks/8.d7942ba7.svg","public/images/masks/9.svg":"//cdn.gotraffic.net/business/public/images/masks/9.4984fa8e.svg","public/images/masks/the_brief/1.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/1.320956b0.svg","public/images/masks/the_brief/10.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/10.e663fed1.svg","public/images/masks/the_brief/11.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/11.2059376b.svg","public/images/masks/the_brief/12.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/12.ed23d773.svg","public/images/masks/the_brief/13.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/13.ee7a5804.svg","public/images/masks/the_brief/14.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/14.ccf4047c.svg","public/images/masks/the_brief/15.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/15.14ec87a2.svg","public/images/masks/the_brief/16.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/16.c71241f4.svg","public/images/masks/the_brief/17.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/17.203c46e2.svg","public/images/masks/the_brief/18.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/18.bdf198b8.svg","public/images/masks/the_brief/19.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/19.a5f0a5d8.svg","public/images/masks/the_brief/2.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/2.b150f74f.svg","public/images/masks/the_brief/20.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/20.2e211202.svg","public/images/masks/the_brief/3.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/3.ba120ffe.svg","public/images/masks/the_brief/4.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/4.97d322bf.svg","public/images/masks/the_brief/5.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/5.427b4e45.svg","public/images/masks/the_brief/6.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/6.394d2c05.svg","public/images/masks/the_brief/7.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/7.f60dd6e3.svg","public/images/masks/the_brief/8.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/8.0fa2f2be.svg","public/images/masks/the_brief/9.svg":"//cdn.gotraffic.net/business/public/images/masks/the_brief/9.b7123eb5.svg","public/images/newsletter-loader.gif":"//cdn.gotraffic.net/business/public/images/newsletter-loader.47c1a967.gif","public/images/no-image-header-BREAKING.jpeg":"//cdn.gotraffic.net/business/public/images/no-image-header-BREAKING.475e12b5.jpeg","public/images/top-noimage-ph.jpeg":"//cdn.gotraffic.net/business/public/images/top-noimage-ph.5d911b62.jpeg","public/javascripts/application.js":"//cdn.gotraffic.net/business/public/javascripts/application.24c97a10.js","public/javascripts/previewModules.js":"//cdn.gotraffic.net/business/public/javascripts/previewModules.dcc88ffc.js","public/javascripts/tophat_snippet.js":"//cdn.gotraffic.net/business/public/javascripts/tophat_snippet.fe0b591b.js","public/stylesheets/application.css":"//cdn.gotraffic.net/business/public/stylesheets/application.a0f2ff04.css","public/stylesheets/snippet_application.css":"//cdn.gotraffic.net/business/public/stylesheets/snippet_application.a45a8dde.css","public/stylesheets/split/application-ie-blessed1.css":"//cdn.gotraffic.net/business/public/stylesheets/split/application-ie-blessed1.7f4d8b85.css","public/stylesheets/split/application-ie-blessed2.css":"//cdn.gotraffic.net/business/public/stylesheets/split/application-ie-blessed2.704006d6.css","public/stylesheets/split/application-ie.css":"//cdn.gotraffic.net/business/public/stylesheets/split/application-ie.f2256d5d.css","public/stylesheets/tophat_snippet.css":"//cdn.gotraffic.net/business/public/stylesheets/tophat_snippet.e3a2a1dc.css"},"bplayerJs":"//cdn.gotraffic.net/projector/latest/bplayer.js","videoPlayerConfig":{"shareOverlay":"true"},"searchHost":"http://search.bloomberg.com","clientApp":"app/ClientApp","snippetApp":"app/SnippetApp","snippetHost":"http://www.bloomberg.com","recommendation":{"site":"bbiz;Unknown","url":"http://personalization.bloomberg.com"},"newRelicAppId":"4892087","disqusShortname":"bloomberg","twitterUser":"business","twitterSite":"@business","tracking":{"chartbeat":{"domain":"bloomberg.com","uid":"15087"},"comscore":{"clientId":"3005059","site":"bloomberg","siteIdentifier":"004"},"googleAnalytics":{"gaAccount":"UA-11413116-1"},"personalization":{"site":"bbiz","trackingUrl":"http://tracking.bloomberg.com/images/tracking-pixel.gif"},"timeouts":{"iframe":2000,"message":3000,"request":3000},"urls":{"tracking":"http://tracking.bloomberg.com/images/tracking-pixel.gif"}}});
snippetApp.start({"host":"http://www.bloomberg.com","viewFunctionNames":["snippetHeaderViews","snippetFooterViews"]});
</script>

<div class='clearfix' id='container'>
<div class='clearfix' id='sign_in'>
<div class='sign_in_frame'>
<span class='login facebook'>
Sign in with Facebook
<span class='facebook_button'>
<a href="#"><span class='inline_icon icons-connect_with_facebook facebook_login'></span>
</a></span>

</span>
<span class='login'>Or use your Businessweek account</span>
<div class='login_form'>
<form accept-charset="UTF-8" action="https://secure.businessweek.com/login" class="new_user_form" id="new_user_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="J3+nCmSSGA710Z8Tx68THoVFUef1hiuiFDsYdmWtOrM=" /></div>
<label class="for_email" for="user_form_email">Email</label>
<input class="" id="user_form_email" maxlength="100" name="user_form[email]" size="100" type="text" />
<label class="password" for="user_form_password">Password</label>
<a href="https://secure.businessweek.com/password/forgot" class="forgot_password">Forgot  password?</a>
<input class="" id="user_form_password" maxlength="20" name="user_form[password]" size="20" type="password" />
<input name="user_form[remember_me]" type="hidden" value="0" /><input id="user_form_remember_me" name="user_form[remember_me]" type="checkbox" value="1" />
<label class="checkbox_label" for="user_form_remember_me">Remember me</label>
<input class="button" name="commit" type="submit" value="Sign In" />
</form>
</div>
<p class='bloomberg_user'>
Already a Bloomberg.com user?
</p>
<p>Sign in with the same account.</p>
<p class='other_options'>
Don't have an account?
<a href="https://secure.businessweek.com/register">Sign up.</a>
</p>
<p class='account-help'>
<a href="https://secure.businessweek.com/users/forgot-account">Help! I can&#x27;t access my account.</a>
</p>

</div>
</div>

<span class='banner_ad top_banner_ad companion_replace'>
<div class='gpt_ads_slot' id='leader_board'>
<div class='gpt_ad_container' data-gpt-size='[[728, 90], [970, 66], [1, 1]]' data-original-position='leader_board' data-position='top' data-pt='t2' data-size='728x90,970x66,1x1' data-tile='3' data-tz='top'></div>
</div>

</span>
<div id='flash'>
</div>

<div class='column_container clearfix'>
<div class='column full_width primary'>
<div id='content'>
<div class='design_full_width'>
<article class='businessweek' itemscope itemtype='http://schema.org/Article'>
<div class='department_text'><h3>Features</h3></div>
<h1 class='headline' itemprop='name headline'>How the U.S. Screwed Up in the Fight Against Ebola</h1>
<div class='design_byline clearfix'>
<div id='authorial'>
<span class='byline'>
<span class='byline-text'>
By <a href="http://www.businessweek.com/authors/416-brendan-greeley" itemprop="name" rel="author">Brendan Greeley</a> and <a href="http://www.businessweek.com/authors/54796-caroline-chen" itemprop="name" rel="author">Caroline Chen</a>
</span>
</span>

<time class='byline-text' datetime='2014-09-24T06:05:58-04:00' itemprop='datePublished'>
September 24, 2014
</time>
</div>
<div class='share_buttons' data-headline='How the U.S. Screwed Up in the Fight Against Ebola' data-host='http://analytics.bloomberg.com/images/analytics-bw/dot1.gif' data-id='23288208-4379-11e4-b585-d8d385601e40' data-ping-uri='/,/politics-and-policy,/bw/politics-and-policy/white-house,/bw/politics-and-policy/africa,/bw/politics-and-policy/health-care,/bw/politics-and-policy/science-and-research,/bw/politics-and-policy/policy,/authors/416-brendan-greeley,/authors/54796-caroline-chen' data-pub-date='2014-09-24 06:05:58 -0400' data-summary="One promising treatment might have averted an epidemic. Why wasn't it ready in time?" data-type='story' data-uri='http://www.bloomberg.com/bw/articles/2014-09-24/ebola-drug-zmapps-development-delayed-by-pentagon-agency'>
<span class='clickable share_button inline_icon icons-facebook_share tracked' data-action-type='Share via Facebook' data-actions='click' data-button-type='facebook' data-category='Sharing' data-label='/articles/2014-09-24/ebola-drug-zmapps-development-delayed-by-pentagon-agency' title='Share on Facebook'></span>
<span class='clickable share_button inline_icon icons-twitter_share tracked' data-action-type='Share via Twitter' data-actions='click' data-button-type='twitter' data-category='Sharing' data-label='/articles/2014-09-24/ebola-drug-zmapps-development-delayed-by-pentagon-agency' title='Share on Twitter'></span>
<span class='clickable share_button inline_icon icons-linked_in_share tracked' data-action-type='Share via LinkedIn' data-actions='click' data-button-type='linkedin' data-category='Sharing' data-label='/articles/2014-09-24/ebola-drug-zmapps-development-delayed-by-pentagon-agency' title='Share on LinkedIn'></span>
<span class='clickable share_button inline_icon icons-gplus_share tracked' data-action-type='Share via Google+' data-actions='click' data-button-type='google_plus' data-category='Sharing' data-label='/articles/2014-09-24/ebola-drug-zmapps-development-delayed-by-pentagon-agency' title='Share on Google+'></span>
<span class='clickable kindleWidget inline_icon icons-send_to_kindle tracked' data-action-type='Sent to Kindle' data-actions='click' data-button-type='kindle' data-category='Sharing' title='Share on Kindle'></span>
</div>

</div>
<hr>
<p class='note'>(An earlier version of this story ran online.)</p>


<div id="lead_graphic"><img alt="How the U.S. Screwed Up in the Fight Against Ebola" data-image-id="398449162" height="643" src="http://images.bwbx.io/cms/2014-09-23/0923_ebola_whitehouse_970.jpg" title="How the U.S. Screwed Up in the Fight Against Ebola" width="970" /><p class="photo_credit">Photograph by Carol M. Highsmith</p></div>

<div class='module advertisement rectangle floating_ad'>
<div class='gpt_ads_slot' id='right2'>
<div class='gpt_ad_container' data-gpt-size='[[300, 250], [300, 600], [300, 1050], [1, 1]]' data-original-position='right2' data-position='right2' data-pt='t2' data-size='300x250,300x600,300x1050,1x1' data-tile='4' data-tz='right2'></div>
</div>

</div>
<div id='article_body' itemprop='articleBody'>
<p>It was a small victory in a grim and runaway catastrophe. In July, Kent Brantly and Nancy Writebol, both American medical workers in Liberia, became stricken with Ebola hemorrhagic fever after treating dozens suffering from the disease, which has a mortality rate of 50 percent to 90 percent. They were rushed doses of an experimental cocktail of Ebola antibodies called ZMapp, flown home via a Gulfstream III on separate flights on Aug. 2 and 5, and each isolated inside a special tent called an “aeromedical biological containment system.” The U.S. Department of State and the Centers for Disease Control and Prevention (CDC) coordinated the flights, operated by Phoenix Air, a private transport company based in Georgia. Cared for in a special ward at Emory University in Atlanta, they recovered within the month and later met with President Obama. It appeared to be a win for the White House.</p>
<p>Mapp Biopharmaceutical, the San Diego company that developed ZMapp, is also in a way a White House project. It’s supported exclusively through federal grants and contracts that go back to 2005. The antibody mixture hadn’t yet passed its first phase of human clinical trials, but after the two Americans were infected with Ebola, the Food and Drug Administration granted emergency access to ZMapp.</p>
<p>It’s too early to say whether ZMapp was vital to the Americans’ survival. There were a limited number of doses available. Mapp ran out after having given doses to the two Americans, a Spanish priest, and doctors in two West African countries, although it declined to say how many. And that raised fair questions: Why hadn’t the promising treatment gone through human clinical trials sooner, and why were there so few doses on hand?</p>
<p><div class="inline_video" width="630" height="420"><video id="video_player" class="video-js vjs-default-skin" controls="" preload="auto" auto-setup="true" data-setup="{&quot;techOrder&quot;:[&quot;flash&quot;,&quot;html5&quot;],&quot;controls&quot;:false,&quot;flash&quot;:{&quot;flashVars&quot;:{&quot;live&quot;:false,&quot;poster_as_slate&quot;:false,&quot;module.com.bloomberg.player.ads::AdPlayer&quot;:&quot;enabled&quot;,&quot;module.com.bloomberg.player.ads::LiveStreamAdSensor&quot;:&quot;enabled&quot;,&quot;ads.preroll.unit&quot;:&quot;mgh.bw.video&quot;,&quot;ads.preroll.gpt&quot;:true,&quot;ads.midroll.unit&quot;:&quot;&quot;,&quot;ads.midroll.gpt&quot;:false,&quot;ads.companions.disable&quot;:false,&quot;ads.playback.timeout&quot;:15000,&quot;ads.vast.timeout&quot;:15000,&quot;ads.live.ads_per_block&quot;:3,&quot;ads.live.playback_delay&quot;:4,&quot;autoplay&quot;:false,&quot;module.com.bloomberg.player.media::MediaController&quot;:&quot;enabled&quot;,&quot;module.com.bloomberg.player.media::MediaLoader&quot;:&quot;enabled&quot;,&quot;module.com.bloomberg.player.media::MediaContainer&quot;:&quot;enabled&quot;,&quot;module.com.bloomberg.player.chrome::Chrome&quot;:&quot;enabled&quot;,&quot;module.com.bloomberg.player.captions::Captions&quot;:&quot;enabled&quot;,&quot;module.com.bloomberg.player.js::JsMediaController&quot;:&quot;enabled&quot;,&quot;module.com.bloomberg.player.js::EventBridge&quot;:&quot;enabled&quot;,&quot;module.com.bloomberg.player.js::UserPreferencesStore&quot;:&quot;enabled&quot;,&quot;module.com.bloomberg.player.reporting::ConvivaInsights&quot;:&quot;enabled&quot;,&quot;log.*.debug&quot;:false,&quot;js.events.callback&quot;:&quot;onPlayerEvent&quot;,&quot;js.playback.callback&quot;:&quot;onPlaybackStatusChange&quot;,&quot;ui.autohide.timeout&quot;:2000,&quot;controls.popout&quot;:false,&quot;controls.fullscreen&quot;:true,&quot;allow_dvr&quot;:false,&quot;ads.preroll.network.id&quot;:5262,&quot;conviva.account&quot;:&quot;c3.Bloomberg&quot;,&quot;conviva.custom.tags&quot;:{&quot;serviceUrl&quot;:&quot;http://livepass.conviva.com&quot;,&quot;Type&quot;:&quot;Video&quot;,&quot;Source&quot;:&quot;BWweb&quot;,&quot;Zone&quot;:&quot;video&quot;},&quot;ui.skin.url&quot;:&quot;http://cdn.gotraffic.net/projector/latest/skin.png&quot;,&quot;buffering.animation&quot;:&quot;http://cdn.gotraffic.net/projector/latest/buffering-animation.gif&quot;,&quot;ads.preroll.suffix&quot;:&quot;story=f0ca7804-26e3-41e7-a6fc-1e9a0ffbf9e1&quot;,&quot;ads.preroll.cust_params&quot;:&quot;story%3Df0ca7804-26e3-41e7-a6fc-1e9a0ffbf9e1&quot;,&quot;poster&quot;:&quot;http://www.bloomberg.com/image/iotavKgY0wEY.jpg&quot;},&quot;params&quot;:{&quot;allowfullscreen&quot;:true,&quot;quality&quot;:&quot;high&quot;,&quot;bgcolor&quot;:&quot;#000000&quot;,&quot;allowscriptaccess&quot;:&quot;always&quot;,&quot;wmode&quot;:&quot;transparent&quot;},&quot;swf&quot;:&quot;http://cdn.gotraffic.net/projector/latest/BloombergPlayer.swf&quot;},&quot;start_time&quot;:0,&quot;plugins&quot;:{&quot;comscoreMatrixPlugin&quot;:{&quot;c3&quot;:&quot;BBG&quot;},&quot;comscoreStreamSensePlugin&quot;:{&quot;ns_site&quot;:&quot;bloomberg&quot;,&quot;page_level_tags&quot;:{},&quot;c4&quot;:&quot;BBG&quot;,&quot;c5&quot;:&quot;02&quot;},&quot;liveDisplayPlugin&quot;:{&quot;enabled&quot;:true},&quot;overlayPlugin&quot;:{&quot;enabled&quot;:false},&quot;childVideoPlugin&quot;:{&quot;enabled&quot;:false},&quot;adClickPlugin&quot;:{}},&quot;use_comscore&quot;:true,&quot;use_clickable_ads&quot;:true,&quot;use_thumbnail&quot;:111011423,&quot;use_chartbeat&quot;:false,&quot;limit_html_player_to&quot;:&quot;&quot;,&quot;asset_protocol&quot;:&quot;http&quot;,&quot;asset_version&quot;:&quot;latest&quot;,&quot;width&quot;:&quot;630&quot;,&quot;height&quot;:&quot;420&quot;,&quot;metadata&quot;:{&quot;id&quot;:&quot;f0ca7804-26e3-41e7-a6fc-1e9a0ffbf9e1&quot;,&quot;title&quot;:&quot;Ebola Is Coming and the U.S. Gov't Screwed Up Treatment&quot;,&quot;duration&quot;:&quot;111000&quot;,&quot;createdate&quot;:&quot;2014-09-23&quot;,&quot;form_type&quot;:&quot;short-form&quot;,&quot;c5&quot;:&quot;02&quot;,&quot;bb_pub_d&quot;:&quot;2014-09-24 06:14:07 -0400&quot;,&quot;show_name&quot;:&quot;&quot;,&quot;ni_codes&quot;:[&quot;DRG&quot;,&quot;GEN&quot;,&quot;US&quot;,&quot;USGOV&quot;,&quot;BBW&quot;,&quot;VIDTVEDI&quot;,&quot;WEBSUBMIT&quot;,&quot;VIDMLDUS&quot;,&quot;VIDMLDBUS&quot;,&quot;VIDYT&quot;,&quot;VIDMLDFEA&quot;,&quot;VIDUSDIGI&quot;],&quot;version&quot;:&quot;latest&quot;}}" width="630" height="420" poster="http://www.bloomberg.com/image/iotavKgY0wEY.jpg" style=" "><source src="http://cdn-mobapi.bloomberg.com/mobapi/v2/ipad/media/video/cc/WiFi/8Mp4BCbjQeem_B6aD_v54Q.m3u8" type="video/mp4" data-bitrate="" data-percent="100"></source><source src="http://b5vod-vh.akamaihd.net/z/m/NjE2MDUyMA/iAGQ1Cbqv4bDEhg9RaplKIJ15PrXt.lXYP5IY_Uv1a1hMGFm/af213b26-38bc-4245-abf0-f9f21d455306_,15,24,44,70,120,180,240,0.mp4.csmil/manifest.f4m?hdcore=1" type="video/mp4" data-bitrate="" data-percent="90"></source><source src="http://cdn.bloomberg.tv.global.prod.fastly.net/z/m/NjE2MDUyMA/iAGQ1Cbqv4bDEhg9RaplKIJ15PrXt.lXYP5IY_Uv1a1hMGFm/af213b26-38bc-4245-abf0-f9f21d455306_,15,24,44,70,120,180,240,0.mp4.csmil/manifest.f4m?hdcore=1" type="video/mp4" data-bitrate="" data-percent="10"></source></video></div></p>
<p>Since appearing in Guinea in December, Ebola has spread to five West African countries and infected 5,864 people, of which 2,811 have died, according to the World Health Organization’s Sept. 22 report. This number is widely considered an underestimate. The CDC’s worst-case model assumes that cases are “significantly under-reported” by a factor of 2.5. With that correction, the CDC predicts 21,000 total cases in Liberia and Sierra Leone alone by Sept. 30. </p>
<p><span class="inline_image center"><img src="http://images.bwbx.io/cms/2014-09-23/0923_ebola_obama_630.jpg" alt="President Obama meets with Kent Brantly and his wife, Amber, in the Oval Office on Sept. 16"><span class="credit">Photograph by Pete Souza/White House</span><span class="figcaption">President Obama meets with Kent Brantly and his wife, Amber, in the Oval Office on Sept. 16</span></span></p>
<p>A confluence of factors has made it the biggest Ebola outbreak yet. For starters, West Africa has never seen Ebola before; previous outbreaks have mainly surfaced in the Democratic Republic of the Congo in Central Africa. The initial symptoms of Ebola—fever, vomiting, muscle aches—are also similar to, and were mistaken for, other diseases endemic to the region, such as malaria.</p>
<p>Then, when officials and international workers swept into villages covered head to toe and took away patients for isolation, some family members became convinced that their relatives were dying because of what happened to them in the hospitals. They avoided medical care and lied to doctors about their travel histories. Medical staff at local hospitals became scared and quit their jobs. Aid workers trying to set up isolation units or trace infected people’s contacts were attacked by angry villagers. With these countries short on resources, staff, medical equipment, and basic understanding of the disease, Ebola took hold and spread.</p>
<p>There have been a number of admirable and vigilant responses, from local doctors and emergency workers to nongovernmental organizations such as Doctors Without Borders. Foreign governments have so far pledged about a third of the $988 million the United Nations says is needed to fight the epidemic. On Sept. 16, the Obama administration announced plans to send 3,000 military personnel to assist with shipping and distribution of medical equipment and supplies. The Americans will also help build treatment centers and train health-care providers in the region. </p>
<p><a href="http://www.businessweek.com/articles/2014-09-25/businessweeks-ebola-cover-how-we-made-it" title="Cover Trail: Ebola Is Coming"><span class="inline_image right"><img src="http://images.bwbx.io/cms/2014-09-23/cover-304.jpg" alt="Behind this week’s cover"><span class="credit">Illustration by 731</span><span class="figcaption">Behind this week’s cover</span></span></a>
</p><p>Could a large stockpile of ZMapp have halted the spread of Ebola? No one can say. What’s certain is that the U.S. government hasn’t done a good job taking the idea behind ZMapp and turning it into a treatment. The technology for antibody cocktails such as ZMapp has “been around for a few decades,” says Robert Garry, a professor of microbiology at Tulane University. “This is something that, given the emergency, the government could have moved a little faster on, quite honestly.” He’s more right than he knows. The treatment came into the hands of a little-known Pentagon agency in late 2010, and, <em>Bloomberg Businessweek</em> has learned, ZMapp sat there dormant, waiting for a contract, for two years.<br> <br> <br>There are, broadly speaking, two ways to spend money on biological defense: on gloves or on drugs. A response to any attack requires a public health infrastructure, things like gowns, boots, masks, and gloves to prevent the spread of infection, training for doctors and nurses, and field hospitals that can be moved to the site of an outbreak. Or a threat can be met with what the federal government calls a “medical countermeasure,” a vaccine to prevent infection or a therapy for recovery. </p>
<p>In the 1990s, after revelations of the Soviet biological and chemical weapons programs and the 1995 sarin gas attack in the Tokyo subway, the U.S. handed its defensive drugmaking to the Pentagon. After 2001, the Pentagon budget for biological and chemical defense rose from $880 million to $1.12 billion. Since then, roughly a third of its total budget, about $3.9 billion, has been designated for a list of “biological threat agents.” The list is classified, but it now numbers 18, according to a 2014 analysis by the U.S. Government Accountability Office. Ebola is almost certainly on this list and likely near the top. The Soviet Union had an Ebola program, and Aum Shinrikyo, the cult that released the sarin gas in Tokyo, sent doctors in 1993 to what’s now the Democratic Republic of the Congo on an unsuccessful mission to get an Ebola sample. </p>
<p><span class="inline_image center"><img src="http://images.bwbx.io/cms/2014-09-23/0923_ebola_un_630.jpg" alt="Members of the Security Council attend a meeting on the Ebola crisis at UN headquarters in New York on Sept. 18"><span class="credit">Photograph by Shannon Stapleton/Reuters</span><span class="figcaption">Members of the Security Council attend a meeting on the Ebola crisis at UN headquarters in New York on Sept. 18</span></span></p>
<p>Then, because the 2001 anthrax attacks on the Capitol in Washington were directed at civilians, the Department of Health and Human Services launched a parallel track in biochemical defense. Soon, the HHS began keeping its own list of biological threats. Over the next two years, the budget at the National Institute of Allergy and Infectious Diseases (NIAID), part of the HHS, jumped from $2.04 billion to $3.7 billion. Two separate arms of the federal government, with a $5 billion annual budget between them, now were focused on the same set of problems but not talking to each other well. And neither was accomplishing what was needed most: producing drugs. </p>
<p>By 2006 the White House became aware of an inefficiency. NIAID’s budget went to sponsor basic research at university and commercial labs, but the agency didn’t move its ideas out of the lab, into trials, and through the FDA approval process. The Pentagon’s program also “never got enough money to be a pharmaceutical company,” says Robert Kadlec. A consultant and public health physician who held several high-level posts in biodefense in the George W. Bush administration, Kadlec says the Pentagon had “enough for research and development, but not for licensure.” </p>
<p><iframe width="315" height="225" frameborder="0" scrolling="no" src="http://www.businessweek.com/graphics/linkbox/ebola-links1.html" style="overflow: hidden; margin-left: -90px; margin-right: 10px; float: left;"></iframe></p>
<p>“For things like Ebola, there is no clear buyer other than the government,” says Thomas Inglesby, the director of the Center for Health Security at the University of Pittsburgh Medical Center who’s advised three White Houses on biosecurity issues. Normally, he notes, market potential “pulls” a drug forward. With relatively rare tropical diseases, “you basically have to start and finish that process” within the government, “because there is no other buyer in the world.”</p>
<p>To hear legislators talk about it, getting treatments through the FDA is like a Hollywood movie in turnaround. “We identified the struggle as the advanced development,” says Senator Richard Burr, a Republican from North Carolina, referring to the challenge of getting promising treatments through trials and approvals. “We called that area sort of ‘the valley of death’ for any product.”  Kadlec helped Burr create an agency to bridge the valley of death, the Biomedical Advanced Research and Development Authority (Barda). Unlike the Pentagon, Barda, a civilian agency, was granted fast-track contracting authority. It would get drugs out of research labs into trials and through to production. </p>
<p>Unfortunately, Barda was underfunded from the start. Pharma companies generally spend about a billion dollars to get a single drug from idea to FDA license. “Look at $100 million for Barda,” says Kadlec, referring to the agency’s annual budget. “We’ve been operating literally on dimes when they need dollars.” In the last months of the Bush administration, he says, he persuaded the president to propose an appropriation of $900 million. Unlike almost every other pet project in Washington, it didn’t make it into the 2009 stimulus bill. </p>
<p><span class="inline_image right"><img src="http://images.bwbx.io/cms/2014-09-23/0923_ebola_map_315.jpg" alt="The San Diego headquarters of Mapp Biopharmaceutical, maker of the experimental drug ZMapp, in August 2014"><span class="credit">Photograph by Frank Duenzl via Newscom</span><span class="figcaption">The San Diego headquarters of Mapp Biopharmaceutical, maker of the experimental drug ZMapp, in August 2014</span></span></p>
<p>Around the same time, Mapp Biopharmaceutical was looking for more money. Founded in 2003, the company has nine employees (as of Aug. 5) and no external investors. For about a decade, it’s taken an approach to Ebola that had been largely abandoned. Rather than develop a vaccine, which triggers the body to create its own antibodies—defenses against a virus—Mapp worked to develop monoclonal antibodies, a ready-made supply that can be introduced into the body as a therapy after infection. The company didn’t respond to requests for comment.</p>
<p>Mapp had been funded through grants from NIAID, the civilian agency that did only basic research. While NIAID continued to fund Mapp until 2013, the grants were small, generally around $1 million a year, enough to keep the lights on but not enough to get ZMapp into clinical trials. Barda, then focused on influenza, didn’t offer a contract. The agency’s spokeswoman, Gretchen Michael, says that “in terms of Ebola, there haven’t been products mature enough to get Barda level of funding” up until ZMapp this year. And so, according to a person familiar with the project who wasn’t authorized to speak, informal communication among scientists brought the company to the Defense Threat Reduction Agency (DTRA), the arm of the Pentagon that would lead it out of the valley of death.<br> <br> <br>In the summer of 2011, right as Mapp was looking for a new sponsor, DTRA was taking a hard look at what it was doing. Created in 1998 largely to counter all weapons of mass destruction, DTRA had taken on the task of developing drugs for the Pentagon because there was no one else to do it. The agency’s leadership toured labs, talked to researchers, and brought in advisers from pharmaceutical companies and academia. The conclusions from that review, laid out in a presentation <em>Bloomberg Businessweek</em> has seen, weren’t encouraging. </p>
<p><span class="inline_image center"><img src="http://images.bwbx.io/cms/2014-09-24/EBOLAgraphic1_REV2.jpg" alt=""></span></p><p>The presentation describes the agency’s work as it was in 2011. Too much effort was wasted on “knowledge products,” or basic science. Unpromising projects weren’t killed and continued to waste money. Drug development was managed around yearly budgets rather than end goals. Efficacy studies, which determine whether drugs work on animals, weren’t complete, nor were safety studies, which test whether a drug is OK for human use. Samples of Ebola were found in a freezer in a containment lab without patient histories, control samples, or even validation that they contained the virus. The samples were safe but useless for drug development. </p>
<p>Overall, the 2011 presentation concluded, the agency lacked “translational S&amp;T project management discipline,” which is a bureaucratic way of saying that there was no way to take ideas and move them down the long path toward a drug approved by the FDA for production or technology ready for the Pentagon to deploy.</p>
<p><img style="margin-left: -90px;" alt="Ebola timeline" src="http://images.bwbx.io/cms/2014-09-24/EBOLAgraphic2_REV3.jpg"></p>
<p>One year later, in a second report, an external Ph.D. researcher looked at DTRA’s projects on technology to detect chemical and biological attacks. He found “a lack of solid technical oversight for a period of years,” and “a near absence of strategic vision, complicated by much programmatic incoherency.” One project suffered from an “egregious lack of coordination.” Another is described as “an unmitigated disgrace, divorced from any sense of reality.” </p>
<p>This was the agency that picked up Mapp. </p>
<p>According to two people familiar with the project who weren’t authorized to speak, Mapp received a commitment from DTRA in February 2011 for MB-003, ZMapp’s predecessor. This means that the antibody had been deemed a worthy idea but needed to go through a review process before any actual money could be disbursed to develop it. And that’s when the ZMapp program really stalled. Unlike Barda, DTRA doesn’t have fast-track contracting authority. Rather, it uses the Pentagon-wide contracting standards. This is slow anywhere in the Department of Defense. At DTRA, it can be agony. </p>
<p><span class="inline_image center"><img src="http://images.bwbx.io/cms/2014-09-23/0923_ebola_virus_630.jpg" alt="The Ebola virus"><span class="credit">Courtesy CDC</span><span class="figcaption">The Ebola virus</span></span></p>
<p>“It was one of the most frustrating places I ever worked,” says Riva Meade. “I lasted 13 months.” Meade, now retired, worked in Pentagon contracting her entire career, much of it at the Defense Advanced Research Projects Agency. Around the same time as the 2011 review, she was brought into DTRA as the chief of the agency’s business division. </p>
<p>Meade describes two problems. First, DTRA’s contracting officers added unnecessary hurdles into an already cumbersome process. They aimed to make the organization what Meade calls “super clean”—no audits, no reviews, no second-guessing. This is difficult for research and development, when the government is frequently buying something it’s never bought before and doesn’t know how to buy it. “They just had a policy where they wanted never to be called out for making mistakes,” says Meade. “If you want to run a shop like that, it’s going to take a long time. I’m not sure it’s a good policy when you’re working in R&amp;D and you need to get things done that the country needs done.” The contracts department also refused to use expertise from other agencies to assess highly technical programs.</p>
<p>Meade’s time as the business chief at DTRA also coincided with a culture clash within the agency, one confirmed by three other people familiar with the agency who declined to speak on the record. DTRA had hired several people with experience at private pharmaceutical companies who were used to killing programs that were going nowhere and spending money on promising ones. </p>
<p><iframe width="315" height="215" frameborder="0" scrolling="no" src="http://www.businessweek.com/graphics/linkbox/ebola-links2.html" style="overflow: hidden; margin-right: -90px; margin-left: 10px; float: right;"></iframe></p>
<p>The new arrivals wanted to drive products through early trials and to always be shipping. Older employees wanted to focus on publishing research and securing academic prestige. “When you work with a group of scientists who believe that the best thing that they can do is have a published paper, you’re not going to get a lot of productivity when it comes to pharmaceuticals,” says Meade. “Published papers are important in that line of work, but that seemed to be more important to them than anything else.” </p>
<p>The people with pharma experience, she says, in turn failed to show the patience necessary to work in any government agency. “Frequently, what [government contracting officers] were requesting was ridiculous,” she says, “but you know what, you just do it.” One trick to federal contracting, she explains, is to know when not to fight. </p>
<p>Kadlec, the former Bush administration official who was still working in biodefense medicine, was well aware of both the delay with Mapp and the more general problems at DTRA. He says other companies working with the agency encountered similar holdups. “It was like, can we do any better than this?” he says. </p>
<p><span class="inline_image center"><img src="http://images.bwbx.io/cms/2014-09-23/0923_ebola_boots_630.jpg" alt="Boots drying after being washed with chlorine at a Doctors Without Borders field hospital in Kailahun, Sierra Leone"><span class="credit">Photograph by Samuel Aranda</span><span class="figcaption">Boots drying after being washed with chlorine at a Doctors Without Borders field hospital in Kailahun, Sierra Leone</span></span></p>
<p>In late 2012, Kadlec wrote a report for the UPMC’s Center for Biosecurity on the potential benefits of monoclonal antibodies, the Mapp approach. The report, he says, was in part designed to nudge DTRA toward completing Mapp’s contract. In it, he suggests that the Pentagon fast-track a few sample projects, including one for “prophylaxis against a fast-moving virus.” Kadlec lays some blame on the Pentagon’s contracting process. “You have to do this like you’re buying an F-35,” he says. “As you well know, a vaccine is not an airplane.”</p>
<p>“The pharma guys lost,” says Meade. In February 2013, Alan Rudolph, whose name appears on several presentations urging streamlined decision-making at DTRA, left the agency. Rudolph’s departure happened to come the same month the agency finally wrote its first check to Mapp Biopharmaceutical. </p>
<p>According to one person familiar with DTRA, without the contract delays, Mapp could have completed trials necessary for either the CDC or the Pentagon to stockpile the drug. The Department of Defense says it’s only because of its forethought that the U.S. has groundbreaking treatments like ZMapp at all. “Since the outbreak took hold, DTRA, along with other partners within the U.S. government, has accelerated its counter-Ebola efforts as much as possible as part of the global response,” say Jennifer Elzea, a DOD spokeswoman. </p>
<p>It’s still uncertain how effective ZMapp is, because only a handful of people have taken it. But doctors would have had a better idea if it hadn’t been stuck in the federal bureaucracy for four years. The drug’s path through the research labs of the Washington-Baltimore corridor shows that the federal government still isn’t good at producing drugs. Barda needs money. DTRA can’t move quickly. And the U.S., until now, hasn’t made Ebola a priority. “That’s why we don’t have an Ebola countermeasure,” says Kadlec. “We failed to invest enough dollars to have it mature.”<br> <br> <br>Even the seemingly straightforward stuff can be hard. This summer, when Obama decided that the U.S. was going to bring home Americans stricken with Ebola, the White House had to deal with pushback. According to two people familiar with the matter who weren’t authorized to speak on the record, the State Department first asked the U.S. Air Force, whose Transportation Command flies C-17 Globemasters outfitted with biological containment systems for sick patients. But the Air Force demurred. Its C-17s fly servicemen. The State Department didn’t respond to a late request for comment on why the government used a private carrier. The Air Force referred questions to the National Security Council. Edward Price, a spokesman for the NSC, says the White House “did not request U.S. military transport.” </p>
<p><span class="inline_image center"><img src="http://images.bwbx.io/cms/2014-09-23/0923_ebola_supplies_630.jpg" alt="A shipment of supplies and equipment arrives in Liberia, the first since President Obama’s speech at the CDC on Sept. 16"><span class="credit">Photograph courtesy U.S. Embassy, Monrovia</span><span class="figcaption">A shipment of supplies and equipment arrives in Liberia, the first since President Obama’s speech at the CDC on Sept. 16</span></span></p>
<p>Biological hazards are difficult to plan for. Any pathogen can pose a threat to troops deployed abroad or citizens at home. It can spread as a weapon or on its own as a natural outbreak. Any plan spends money on something that hasn’t happened yet, something difficult for any president to do. And it forces different federal agencies to work well together, something no U.S. president has yet accomplished. According to Kadlec, Bill Clinton became alarmed about bioterror toward the end of his administration. George W. Bush fired Clinton’s bioterror adviser, then rehired him after Sept. 11. Dick Cheney was consumed by bioterror. Obama is now. And he’s handling a situation none of his predecessors planned for: a natural foreign outbreak that may destabilize countries and become a national security risk. </p>
<p>Barda now has given Mapp Biopharmaceutical a $25 million contract to start clinical trials with ZMapp. This is encouraging, but it hasn’t fixed the problem. The Pentagon and the HHS have a list of threats, and no real way to work down the list, devising treatments and getting them through the FDA’s approval process. </p>
<p>Every outbreak will make every administration look feckless and incompetent. But the U.S., at the very least, needs to admit to itself that to improve readiness, it needs to function like a drugmaker—and be good at it. “As long as there’s not sufficient money to address every one of the targeted diseases,” says Senator Burr, “it’s going to force the system to make a decision based on what’s the greatest threat today.”</p>
</div>
</article>

<div class="contributor">With Josh Eidelson</div>
<div class='design_bio clearfix'>
<div class='author_bio_container'>
<div class='author_bio_image'>
<span class="headshot"><img alt="Greeley-brendan-190" src="http://images.bwbx.io/cms/2013-10-07/Greeley-Brendan-190.jpg" width="40" /></span>
</div>
<div class='author_short_bios'>
<a href="mailto:bgreeley2@bloomberg.net">Greeley</a> is a staff writer for <cite>Bloomberg Businessweek</cite> in New York.
</div>
</div>
<div class='author_bio_container'>
<div class='author_short_bios'>
<a href="mailto:cchen509@bloomberg.net">Chen</a>  is a reporter for Bloomberg News in New York.
</div>
</div>

<div class='share_buttons' data-headline='How the U.S. Screwed Up in the Fight Against Ebola' data-host='http://analytics.bloomberg.com/images/analytics-bw/dot1.gif' data-id='23288208-4379-11e4-b585-d8d385601e40' data-ping-uri='/,/politics-and-policy,/bw/politics-and-policy/white-house,/bw/politics-and-policy/africa,/bw/politics-and-policy/health-care,/bw/politics-and-policy/science-and-research,/bw/politics-and-policy/policy,/authors/416-brendan-greeley,/authors/54796-caroline-chen' data-pub-date='2014-09-24 06:05:58 -0400' data-summary="One promising treatment might have averted an epidemic. Why wasn't it ready in time?" data-type='story' data-uri='http://www.bloomberg.com/bw/articles/2014-09-24/ebola-drug-zmapps-development-delayed-by-pentagon-agency'>
<span class='clickable share_button inline_icon icons-facebook_share tracked' data-action-type='Share via Facebook' data-actions='click' data-button-type='facebook' data-category='Sharing' data-label='/articles/2014-09-24/ebola-drug-zmapps-development-delayed-by-pentagon-agency' title='Share on Facebook'></span>
<span class='clickable share_button inline_icon icons-twitter_share tracked' data-action-type='Share via Twitter' data-actions='click' data-button-type='twitter' data-category='Sharing' data-label='/articles/2014-09-24/ebola-drug-zmapps-development-delayed-by-pentagon-agency' title='Share on Twitter'></span>
<span class='clickable share_button inline_icon icons-linked_in_share tracked' data-action-type='Share via LinkedIn' data-actions='click' data-button-type='linkedin' data-category='Sharing' data-label='/articles/2014-09-24/ebola-drug-zmapps-development-delayed-by-pentagon-agency' title='Share on LinkedIn'></span>
<span class='clickable share_button inline_icon icons-gplus_share tracked' data-action-type='Share via Google+' data-actions='click' data-button-type='google_plus' data-category='Sharing' data-label='/articles/2014-09-24/ebola-drug-zmapps-development-delayed-by-pentagon-agency' title='Share on Google+'></span>
<span class='clickable kindleWidget inline_icon icons-send_to_kindle tracked' data-action-type='Sent to Kindle' data-actions='click' data-button-type='kindle' data-category='Sharing' title='Share on Kindle'></span>
</div>

</div>
<hr>
</div>
<div class='slideout_container' data-show-slideout?='yes'></div>

</div>
</div>
<div class='column rail'>

</div>
</div>
<div class='bottom_container clearfix'>
<div class='bottom_column primary'>
<div class='taboola_bottom' id='taboola_wrapper'>
<div id='taboola-below-main-column'></div>
<div id='taboola-bmc-mix'></div>
</div>

<a href="https://subscribe.businessweek.com/servlet/OrdersGateway?cds_mag_code=BWK&amp;cds_page_id=160309" class="sub_sales"><div class='sub_sales-cover'>

</div>
<div class='sub_sales-background'>
<div class='sub_sales-content'>
<span class='sub_sales-offer'>
LIMITED-TIME OFFER
</span>
<span class='sub_sales-subscribe'>
SUBSCRIBE NOW
</span>
</div>
</div>
</a>
<div id='disqus_thread'></div>


</div>
<div class='bottom_column rail'>
<div class='module advertisement rectangle'>
<div class='gpt_ads_slot' id='right3'>
<div class='gpt_ad_container' data-gpt-size='[[300, 250], [1, 1]]' data-original-position='right3' data-position='right3' data-pt='t2' data-size='300x250,1x1' data-tile='6' data-tz='right3'></div>
</div>

</div>
<div class='clearfix module' id='google_ads'>
<h3>Ads by Google</h3>
<ul></ul>
</div>




</div>
</div>





</div>
<div class="snippet-view business-snippet default-layout section-front" data-view-uid="snippetFooterViews"><div data-view-uid="snippetFooterViews_1"><footer id="footer" class="footer">
    <div class="footer__container">
        <ul class="footer__links">
            <li class="footer__link"><a href="http://www.bloomberg.com/tos">Terms of Service</a></li>
            <li class="footer__link"><a href="http://www.bloomberg.com/trademarks">Trademarks</a></li>
            <li class="footer__link"><a href="http://www.bloomberg.com/privacy">Privacy Policy</a></li>
            <li>
                <p class="footer__copyright">©2015 Bloomberg L.P. All Rights Reserved</p>
            </li>
        </ul>

        <ul class="footer__links">
            <li class="footer__link"><a href="http://jobs.bloomberg.com/">Careers</a></li>
            <li class="footer__link"><a href="http://nytm.org/made-in-nyc">Made in NYC</a></li>
            <li class="footer__link"><a href="http://www.bloomberg.com/privacy#advertisements">Ad Choices <img src="//cdn.gotraffic.net/business/public/images/icons/ad_choices_icon.49173bcd.png"></a></li>
            <li class="footer__link"><a href="http://www.bloomberg.com/feedback">Website Feedback</a></li>
            <li class="footer__link"><a href="http://www.bloomberg.com/help/">Help</a></li>
            <li class="footer__link"><a href="http://www.bloomberg.com/sitemap">Sitemap</a></li>
        </ul>
    </div>
</footer>
</div></div>


<script src="http://static.btrd.net/assets/gpt_ads-17bd6d266c9884f927d44c22606dea3e.js" type="text/javascript"></script>
<script src="http://static.btrd.net/assets/application-aca93c88a964190da8ef4fb7ac9170a9.js" type="text/javascript"></script>
<script>
  var _gaq=[["_setAccount","UA-11413116-1"],["_trackPageview"],["_trackPageLoadTime"]];
  (function(d,t){var g=d.createElement(t),s=d.getElementsByTagName(t)[0];g.async=1;
  g.src=("https:"==location.protocol?"//ssl":"//www")+".google-analytics.com/ga.js";
  s.parentNode.insertBefore(g,s)}(document,"script"));
</script>

<script src="http://static.btrd.net/assets/jquery.bloomberg_hat-7c768497a3670c3f9da1b9420a9c3801.js" type="text/javascript"></script>
<script src="http://static.btrd.net/assets/jquery.truste-consent-1f59258579d7f178906f4d9042377f96.js" type="text/javascript"></script>


<link href="http://cdn.gotraffic.net/projector/latest/bvp.css" media="screen" rel="stylesheet" type="text/css" /><script src="http://cdn.gotraffic.net/projector/latest/video.js" type="text/javascript"></script>
<script>
  googletag.cmd.push(function() { googletag.display('header-companion-ad'); });
</script>
<script>
  try {
    $(window).load(function() {
      $('.branding_hat').bloomberg_hat({ 'active_link':'businessweek'}, function(){
        BLOOMBERG.bw_user.init_sign_in_box();
      }); //create the hat, all markup is in the jquery plugin file
  
    $.each(
      $('.lazy'), function(index, value){ 
        $(value).attr('src', $(value).attr('data-original')); 
      }
    );
  
    });
  } catch(err){}
  
  try {
    var tracking_code = window.location.hash.match(/#r=[a-zA-Z_-]*/);
    if (tracking_code != null && tracking_code != "" && tracking_code.length > 0)
      _gaq.push(['_trackEvent', tracking_code[0], document.referrer, location.href]);
  } catch(err){}
  
  // Lazy load navigation submenus, see also layouts/_navigation
  $('#global_nav').ready(function() {
    var params = window.location.href.split('?');
    if (params.length == 2) {
      pass_along_params = "?" + params[1];
    } else {
      pass_along_params = "";
    }
  });
</script>
<script src='http://pagead2.googlesyndication.com/pagead/show_ads.js'></script>
<script>
  function disqus_config() {
    this.callbacks.onNewComment = [function() { trackComment(); }];
  };
  
  function trackComment(){
    var tracking_img_src = "http://analytics.bloomberg.com/images/analytics-bw/dot1.gif?id=23288208-4379-11e4-b585-d8d385601e40&pub_date=2014-09-24 06:05:58 -0400&type=story&activity_type=discussed&uri=/,/politics-and-policy,/bw/politics-and-policy/white-house,/bw/politics-and-policy/africa,/bw/politics-and-policy/health-care,/bw/politics-and-policy/science-and-research,/bw/politics-and-policy/policy,/authors/416-brendan-greeley,/authors/54796-caroline-chen";
    $('body').append('<img src="'+tracking_img_src+'" style="visibility:hidden;" />');
  };
  
  var disqus_shortname  = "bwbeta";
  var disqus_identifier = "23288208-4379-11e4-b585-d8d385601e40";
  var disqus_title      = "How the U.S. Screwed Up in the Fight Against Ebola";
  var disqus_developer  = 0;
  var disqus_url        = "http://www.bloomberg.com/articles/2014-09-24/ebola-drug-zmapps-development-delayed-by-pentagon-agency" ;
  
  /* * * DON'T EDIT BELOW THIS LINE * * */
  $(window).load(function() {
    var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true;
    dsq.src = 'http://' + disqus_shortname + '.disqus.com/embed.js';
      (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq);
  });
</script>
<div id='BF_WIDGET_1'>&nbsp;</div>

<!-- BEGIN DISQUS -->
<a class='dsq-brlink' href="http://disqus.com" title='blog comments powered by'>
blog comments powered by
<span class='logo-disqus'>
Disqus
</span>
</a>
<!-- END DISQUS -->

<script>
  $(window).bind("load", function() {
      var tracking_img_src = "http://analytics.bloomberg.com/images/analytics-bw/dot1.gif?id=23288208-4379-11e4-b585-d8d385601e40&pub_date=2014-09-24 06:05:58 -0400&type=story&activity_type=read&uri=/,/politics-and-policy,/bw/politics-and-policy/white-house,/bw/politics-and-policy/africa,/bw/politics-and-policy/health-care,/bw/politics-and-policy/science-and-research,/bw/politics-and-policy/policy,/authors/416-brendan-greeley,/authors/54796-caroline-chen";
      $('body').append('<img src="'+tracking_img_src+'" style="visibility:hidden;" />');
  });
</script>

<script>
  __reach_config = { 
    pid: '530523d097b0c9220a00000b', 
    title: "Ebola Drug ZMapp's Development Delayed by Pentagon Agency - Businessweek", 
    url: 'http://www.bloomberg.com/articles/2014-09-24/ebola-drug-zmapps-development-delayed-by-pentagon-agency', 
    date: '2014-09-24T06:05:58-04:00', 
    authors: ["Brendan Greeley", "Caroline Chen"], 
    channels: ["politics_and_policy"], 
    tags: ["Features"], 
    iframe: true, 
    ignore_errors: false, 
  }; 
  
  (function(){ 
    var s = document.createElement('script'); 
    s.async = true; 
    s.type = 'text/javascript'; 
    s.src = document.location.protocol + '//d8rk54i4mohrb.cloudfront.net/js/reach.js'; 
    (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(s); 
  })();
</script>
<div id='parsely-root' style='display: none'>
<div data-parsely-site='businessweek.com' id='parsely-cfg'></div>
</div>
<script>
  (function(s, p, d) {
    var h=d.location.protocol, i=p+"-"+s,
        e=d.getElementById(i), r=d.getElementById(p+"-root"),
        u=h==="https:"?"d1z2jf7jlzjs58.cloudfront.net"
        :"static."+p+".com";
    if (e) return;
    e = d.createElement(s); e.id = i; e.async = true;
    e.src = h+"//"+u+"/p.js"; r.appendChild(e);
  })("script", "parsely", document);
</script>
<script>
  $(window).load(function() {
    var REMOTE = "https://secure.businessweek.com";
  
    var xhr = new easyXDM.Rpc({
        local: "/easyxdm/name.html",
        swf: REMOTE + "/easyxdm/easyxdm.swf",
        remote: REMOTE + "/easyxdm/cors/",
        remoteHelper: REMOTE + "/easyxdm/name.html"
    }, {
        remote: {
            request: {}
        }
    });
  
    BLOOMBERG.bw_user.ajax_sign_on = function(form) {
  
      $(".report_error").remove();
      form.find('input').removeClass("error");
  
      request = {
          url: "https://secure.businessweek.com/login",
          method: "POST",
          data: {
                  email : $('#new_user_form #user_form_email').val(),
                  password : $('#new_user_form #user_form_password').val(),
                  remember_me : $('#new_user_form #user_form_remember_me').val()
          }
      }
  
      var responseHandler = function(response) {
          var json = easyXDM.getJSONObject().parse(response.data);
          if (json.message == "success") {
            $('.sign_in_frame').fadeOut("fast", function() {BLOOMBERG.bw_user.replace_with_username('#sign_in')});
          }
      };
  
      var errorHandler = function(error) {
          var json = easyXDM.getJSONObject().parse(error.data.data);
          if(json.message == "migrate"){
             window.location = json.url;
          } else {
            $("<span class='report_error'>"+json.message+"</span>").insertBefore($("#user_form_email"));
            $('#new_user_form input').addClass("error");
          }
      };
      xhr.request(request, responseHandler, errorHandler);
    };
  });
</script>
<script>
  $(".facebook_button").bind('click', function(e) {
    e.preventDefault();
    FB.login(function(response) {
      if(response && response.status == 'connected' ){
        login_with_facebook();
      }
     }, {scope: 'email'});
  });
  
  $(".facebook_link_button").bind('click', function(e) {
    e.preventDefault();
    FB.login(function(response) {
      if(response && response.status == 'connected' ){
        link_account(response);
      }
     }, {scope: 'email'});
  });
  
  function show_protected_content(){
    $("#facebook_wall").hide();
    $('.protected_content').removeClass('protected_content');
    if ( $('body').hasClass('article_old_article')){
      $('body.article_old_article #story_body div.unprotected_content').remove();
      $('body.article_old_article #story_body p.sign_in').remove();
    }
  };
  
  function login_with_facebook() {
  
    var REMOTE = "https://secure.businessweek.com";
  
    var xhr = new easyXDM.Rpc({
        local: "/easyxdm/name.html",
        swf: REMOTE + "/easyxdm/easyxdm.swf",
        remote: REMOTE + "/easyxdm/cors/",
        remoteHelper: REMOTE + "/easyxdm/name.html"
    }, {
        remote: {
            request: {}
        }
    });
  
    request = {
        url: "https://secure.businessweek.com/auth/facebook/callback",
        method: "GET",
        data: {
        referrer_url : window.location.href
        }
    }
  
    var responseHandler = function(response) {
        reg_enabled = "true";
        if (reg_enabled == "true"){
          $('.sign_in_frame').html('<span class="success">Success!</span>');
          $('#sign_in a.opened').removeClass('opened');
          $('.sign_in_frame').fadeOut("fast", function() {BLOOMBERG.bw_user.replace_with_username('#sign_in')});
          if ($('body').hasClass('registration')){
            var json_response = easyXDM.getJSONObject().parse(response.data)
            window.location = json_response.url;
          }
        }
    };
  
    var errorHandler = function(error) {
    };
    xhr.request(request, responseHandler, errorHandler);
  };
  
  function link_account(facebook_user) {
    $.ajax({
      type: "POST",
      data: facebook_user,
      dataType: "json",
      url: "https://secure.businessweek.com/users/link-account",
      success: function(response) {
        $('.facebook_account').html('<a href="http://www.businessweek.com/users/unlink-account" class="unlink_facebook"> Unlink your facebook account</a>');
        $(".unlink_facebook").bind('click', function(e) {
          e.preventDefault();
          BLOOMBERG.bw_user.unlink_account(e);
        });
      },
      error: function(response){
        $('.errors').append(JSON.parse(response.responseText)["message"]);
      }
    });
  }
</script>
<script>
  $(window).load(function(){
     if(true == true){
        BLOOMBERG.bw_user.show_reg();
     }
  });
</script>

<!-- BEGIN DISQUS COMMENTS COUNT -->
<script>
  var disqus_shortname  = "bwbeta";
  var disqus_developer  = 0;
  var s = document.createElement('script'); s.async = true;
  s.type = 'text/javascript';
  s.src = ('https:' == document.location.protocol ? 'https://' : 'http://')  + disqus_shortname + '.disqus.com/count.js';
  (document.getElementsByTagName('HEAD')[0] || document.getElementsByTagName('BODY')[0]).appendChild(s);
</script>
<!-- END DISQUS COMMENTS COUNT -->


<script src="http://static.btrd.net/assets/interstitial-024ac073073e2eed55f3891bb6d35cbf.js" type="text/javascript"></script>
<div id='showInterstitial'>
<div id='backgroundInterstitial'></div>
<div id='intro_ad_header'>
<div id='skip_ad'>
<a class='skip-ad' onclick='disableInterstitial(); return false;'>Continue to Businessweek</a>
</div>
</div>
<div id='intro_ad'>
<div id='ad-interstitial'>
<script>
  var interstitialStatus = 0;
  hideIntroAd();
</script>
<script>
  if (show_interstitial_ad()) {
    var site = AD_SITE+AD_SUB_SITE+AD_ZONE;
    var noad = 0;
    var size = "640x480";
    var url  = (window.location.pathname == undefined) ? "/" : ""+window.location.pathname;
    var tile = 1;
    var dcopt  = (parseInt(tile) == 1) ? "ist" : "";
    var keyword = (AD_KEYWORD != "") ? AD_KEYWORD : "";
    var tz = "interstitial";
    var pt = "t2";
    googletag.cmd.push(function() {
      var slot = googletag.defineSlot('/' + GPT_NETWORK_ID + '/' + site, [640, 480], "ad-interstitial");
      slot.addService(googletag.pubads());
      slot.setTargeting("sz", size);
      slot.setTargeting("url", url);
      slot.setTargeting("tile", tile);
      slot.setTargeting("dcopt", dcopt);
      slot.setTargeting("keyword", keyword);
      slot.setTargeting("page", pt);
      slot.setTargeting(pt, tz);
      googletag.enableServices();
      googletag.cmd.push(function() { googletag.display("ad-interstitial") });
    });
  }
</script>
</div>
</div>
</div>

<!-- BEGIN COMSCORE -->
<script>
  BBBW_comScore.params = {"name":null,"bb_c_type":"story","bb_author":"Brendan Greeley,Caroline Chen","bb_pub_d":"20140924","bb_attributor":"","bb_cg_1":"Politics & Policy","bb_cg_2":"White House","bb_cg_3":"How the U.S. Screwed Up in the Fight Against Ebola","bb_groupid":"","bb_brand":"bbiz","bb_migrated":"bw"};
  if (_BUCKET != "" && _BUCKET_GROUP != ""){
    BBBW_comScore.params['bb_bucket']       = _BUCKET;
    BBBW_comScore.params['bb_bucket_group'] = _BUCKET_GROUP;
  }
  BBBW_comScore.track();
  BBBW_comScore.write_cookie(comScore_track_key,"",-1);
</script>
<noscript>
<p>
<img alt='*' height='1' src='http://b.scorecardresearch.com/p?c1=2&amp;amp;c2=3005059' width='1'>
</p>
</noscript>
<!-- END COMSCORE -->

<!-- Chartbeat Monitoring -->
<script>
  var _sf_async_config= {uid: 15087, domain: "bloomberg.com"};
  _sf_async_config.useCanonical = true;
  
  _sf_async_config.sections = "Politics & Policy";
  _sf_async_config.authors = "Brendan Greeley,Caroline Chen";
  
  
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
        (("https:" == document.location.protocol) ? "https://s3.amazonaws.com/" : "http://") + "static.chartbeat.com/js/chartbeat_pub.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ? loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>



<!-- Last Update: 2015-01-30 18:54:44 -0500 -->

</body>
</html>

